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ABSTRACT
This study correlated the performance accuracy of 
peripheral blood differentials evaluated by clinical 
laboratory scientists and clinical laboratory technicians. 
Fifty-one senior-year students from four clinical laboratory 
science baccalaureate programs and 37 second-year students 
from five clinical laboratory technician programs were given 
10 peripheral blood differentials to perform. Results were 
compared to the values assigned by the Rajamaki method of 
proficiency testing. There was a significant discrepancy in 
the levels of accuracy between the two cohorts, suggesting 
that the results of peripheral blood differentials performed 
by clinical laboratory technicians is suspect. Facilities 
wishing to maintain or improve the quality of laboratory 
services should consider allowing only baccalaureate level 
clinical laboratory scientists to perform peripheral blood 
differentials.
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CHAPTER 1: Introduction to the Study
Introduction
The history of the clinical laboratory has two 
beginnings: first, in ancient times when the primitive 
evaluation of body excreta was first conceived, and again 
in the early 1900s when the structure of the modern 
clinical laboratories evolved. Many elements of the 
evolution of the modern clinical laboratory deserve 
inquiry, including the development of personnel 
standards, the incorporation of automation and 
computerization, as well as the effects of national 
regulations and agencies such as managed care 
organizations now pressing on our ability to deliver 
reliable services.
One issue impacting the credibility of laboratory 
data in the diagnosis and treatment of disease has been 
the evolution of personnel standards for education and 
training of laboratory employees. If these personnel are 
not capable of producing accurate and complete results, 
then the trust in laboratory results by patients and 
physicians alike may be misplaced.
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Background
This study was conducted in an environment that assumed 
the central and peripheral realities of the development and 
current organization of the field of clinical laboratory 
science since 1850 (Williams, 1971). During this time, 
physician pathologists have had a variable influence on the 
quality of preparation and service of medical technologists. 
From the initial significant impact through periods of 
indifference, apathy, and reasserted influence, this 
exogenous stress has resulted in an uneven array of 
regulations, traditions, and practice paradigms with little 
known or verified underpinning for the current practice, 
education versus training, skill set and service ability for 
clinical laboratory scientists, clinical laboratory 
technicians, or other practitioners at the certificate, 
graduate or doctoral level in an arena of 600,000 
individuals. The confusion and hostilities resulting have 
only become more acute during the recent times of cost 
control (Berson, 1989), alternate method of health care 
delivery (Wolper & Pena, 1981), and practitioner shortage 
(Griffith, 2000).
While the history of this field can, in technical ways, 
be traced back to 1550 B.C.E. (Herrick, 1937) with references 
to diagnostic tests in the Ebers Papyrus, the scientific
beginnings were more probably initiated during the 14t 1̂
century (Fagelson, 1961) and the employment of Alessandra
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Giliari at the University of Bologna, and in the United 
States to the University of Michigan in 1844 (Vaughan, 1926) 
at the laboratory of Dr. Victor C. Vaughan prior to the 
opening of a medical school or hospital at the same site.
The utility of such an arrangement was so pronounced that 
other such laboratories were started, leading to the declared 
"need" for pathologists by the staff of the Cook County 
Hospital in 1865 (Hirsch & Billings, 1966).
Advances in basic and medical sciences created the
demand for clinical pathology laboratories late in the 1 9 ^
century. Prior to this time, the average physician performed 
and interpreted nearly all prevailing laboratory procedures 
himself. These procedures were typically limited to simple 
blood counts, urinalysis, and histology examinations (Arens, 
1952; Starr, 1982). Later, others with varying levels of 
education and experience performed tests and reported the 
results. Training of medical students and specialized 
"technicians" followed in great earnest, including the first 
university program in 1922 (Hovde, 1957).
What was important from the outset and is important 
today is the role of accuracy in the performance and 
reporting of laboratory values. Accuracy can be compromised 
by many factors: specimen collection, personnel, 
instrumentation, and reporting. Each attribute can and 
should be studied independently before one can make supported 
statements concerning the quality of clinical laboratory 
results. If one test result is judged to be unreliable, then
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all test reports might be similarly devalued in the intense 
environment of medical diagnosis and monitoring.
Not until the middle of the 2 0 ^  century was the concept
of objective quality control applied to the laboratory, and 
it has remained one of the most important aspects of 
laboratory regulation (Sunderman, 1992). While the current 
proficiency testing construct is concerned with 
interlaboratory testing, only the work of Lunz, Castleberry, 
James, and Stahl (1987) has looked at the educational levels 
of the persons actually performing the tests. This 
investigation tested and proved the premise that laboratories 
employing practitioners credentialed by a single agency (the 
Board of Registry of the American Society of Clinical 
Pathologists) produced more accurate results than those 
laboratories that employed noncredentialed practitioners.
Lunz et al. (1987) asked two groups of practitioners to 
perform a routine chemistry test and their results were 
compared to the known value of the specimen. This study was 
quite small in that the tested population consisted of 25 
persons and each person reported only one result. The 
personnel involved were not observed during the performance 
of this test so there was no way to be sure that the 
specimens were all handled in the same fashion.
Additionally and perhaps more importantly, the work of 
Lunz, Castleberry, and Stahl (1987) compared the accuracy of 
results between baccalaureate level personnel and personnel 
trained in an informal, on-the-job fashion. The certified
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baccalaureate level personnel had all completed identical 
programs of study and had successfully passed the same 
national certification examination, while the uncertified 
personnel could have been exposed to training periods that 
varied greatly in length and intensity and possessed a high 
school diploma. Finally, while only these two types of 
individuals were studied, there are multiple certification 
agencies and multiple levels of educational attainment within 
the American clinical laboratory.
The roles of pathologists and other clinical laboratory 
personnel (certificate holders, associate, baccalaureate, 
masters, and doctoral degree level prepared practitioners) 
initially synchronous, have diverged and come together 
randomly over the past century and more, each driven by 
different motivations and circumstances. The circumstances 
have resulted in the training, education, and employment 
realities of the present day. None of these realities 
developed from carefully thought-out planning but rather from 
a haphazard "solve the imperative of the moment" approach.
The result is that we now have persons "trained" or 
"educated" for certain periods of time rather than until the 
attainment of specific competencies.
For example, it is possible to train a child to 
recognize the difference between a Chevrolet and a Porsche 
without his/her understanding any of the principles of 
internal combustion. Indeed, it is possible to suggest that 
the pattern recognition inherent in this activity is
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independent of any intellectual understanding and that 
accuracy of the identification might be higher in a person 
without knowledge of the basic principles of an automobile 
engine. When pathologists invented the medical laboratory 
technician (MLT), they took this opinion and made it fact 
without any study or proof.
The concept was that the MLT would be competent to 
perform "normal" differentials and able to identify the 
presence of abnormal cells and then to notify a supervisor 
who would perform the differential. This meant the MLT 
should be able to correctly identify all cells normally found 
in the peripheral blood and to differentiate between those 
cells and cells that do not belong in the peripheral blood.
As the years progressed, it was postulated that the MLT could 
actually perform all peripheral blood differentials, thus 
allowing the clinical laboratory scientist to perform other 
procedures or supervision.
The initial Board of Registry task listing for the MLT 
included the identification of normal blood cells. The 1980 
Board of Registry examination outline stated that one 
photomicrograph of a hematologic element would be found in 
the MLT examination format (Board of Registry, 1980). In the 
2000 publication of the National Credentialing Agency for 
Medical Laboratory Personnel Task Analysis, the clinical 
laboratory technician (CLT) examination contains 0-1 blood 
cell photomicrograph for identification out of the 40 
questions in the Hematology content area (NCA Report, 2000).
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These photomicrographs are typically of classic 
presentations of commonly seen normal cells. Further, the 
specific cell is clearly marked with an arrow to focus the 
questioner's response. Because it is only one question out 
of 40, it is possible for an individual taking these 
examinations to misidentify the cell in question and still 
pass the examination. The student is never told which 
questions were answered correctly or incorrectly. Programs 
are given grouped accuracy data by question but are never 
told which question was the photomicrograph, so no analyses 
at a programmatic level has ever been done.
Neither of these certification examinations is capable 
of answering if the skill needed to identify cells is related 
to level of education. Since the basis that exists for 
associate degree level personnel to perform manual 
differentials is a combination of the unproven assertion of 
pathologists and the tacit acceptance by the clinical 
laboratory science profession, it is necessary to build a 
solid body of objective evidence on this skill.
Statement of the Problem
There has been no evidence to support the claims of 
clinical laboratory practitioners who have completed an 
associate degree program that they are competent to perform
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peripheral blood differentials. It has been assumed that, 
because these practitioners are taught this skill, they can 
perform it to a high level. Circumstantial evidence from 
specific questions on certification examinations requiring 
the candidate to correctly identify a cell is not compelling. 
There are no published data concerning the national 
percentage of correct answers on these questions. One study, 
performed in the late 1980s that provides data for the 
baccalaureate level clinical laboratory practitioner. In 
today's managed health care system, laboratory administrators 
are using more and more associate degree employees in place 
of higher paid baccalaureate level employees.
The National Accrediting Agency for Clinical Laboratory 
Sciences (NAACLS) is developing new accreditation standards 
that would place more routine testing into the hands of the 
associate degree personnel and less into the hands of the 
baccalaureate degree personnel (NAACLS, 2000). NAACLS 
believes that routine testing should move from the domain of 
the baccalaureate level practitioner and be replaced by 
additional managerial and administrative activities. Before 
this shift in curriculum takes place, the one concern that 
must be addressed is the level of accuracy achieved by these 
practitioners.
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Purpose of the Study
The purpose of this study was to assess the accuracy of 
peripheral white blood cell identification during the 
performance of a manual peripheral blood differential test. 
The study compared the results from 10 different peripheral 
blood samples as reported by students participating in a 
baccalaureate degree curriculum and students participating in 
an associate degree curriculum. The correlation provided a 
base for the discussion of entry-level competencies for these 
practitioner levels and, perhaps, a restructuring of 
laboratory task assignments, pay scales, and career 
opportunities.
Significance of the Study
The clinical laboratory provides the largest body of 
objective, scientifically validated data on the individual 
patient. At the basic level, the purpose of this study tried 
to determine if the level of education in clinical laboratory 
science is important in the performance of the complete blood 
count differential. The complete blood count (CBC) is one of 
the cornerstone tests in the clinical laboratory. It is 
performed at least once on every hospital patient upon 
admission. It is repeatedly referred to throughout a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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patient's hospital stay. It is the basis of all decisions 
concerning the continuation and/or dosage of oncologic drugs 
and radiation therapy. It provides the information required 
to support diagnoses of anemias such as iron deficiency and 
sickle cell disease, leukemias and lymphomas, inherited white 
blood diseases, platelet associated diseases, and many 
others. It provides data on the efficacy of many other 
medications, from the somewhat innocuous (e.g., multi­
vitamins) to the life sustaining (e.g., coumarin).
A subpart of the CBC is performed by a single person 
viewing blood cells with the aid of a microscope. No one 
else ever sees these cells, yet the differential examination 
is considered the most important portion of this test. In 
the text regarded as the standard for hematology, the late 
Maxwell Wintrobe (1951) described the differential as the 
"most important of all hematology tests" (pg. 266) . 
Additionally, he warned that physicians in 1951 "were too 
ready to accept at face value the results of laboratory 
procedures." This reliance on the laboratory has increased 
so steadily that physicians now are dependent on laboratory 
results for a significant part of their diagnostic, 
therapeutic, and prognostic decision-making without 
themselves having much (if any) training in the intricacies 
of performance or correlative interpretation for many of 
these tests, now numbering over 24,000 (CBC, 1999) .
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At a more abstract level, this study should help to 
define minimum standards of practice. And, at an even more 
abstract level, this study could begin to address a larger 
societal issue. Over the past several decades, our society 
has chosen to deliberately lessen entry-level standards in 
many fields. In health care, we now accept physician 
extenders such as physician assistants and nurse 
practitioners. LPNs routinely perform duties once assigned 
to RNs. Pharmacies routinely employ pharmacy technicians, 
many of whom have only a high school education. It is 
important to note that none of these adjuvant roles have ever 
been evaluated for competence, just as there have never been 
any studies of which this author is aware to justify the use 
of paralegal assistants in the legal profession or lesser 
qualified part-time instructors in colleges and universities. 
An ad hominun case could be made that the contemporary task 
reassignment or practitioner re-creation has its origin in 
expedient economy and personnel availability rather than the 
medical needs of a patient or the legal needs of a client, 
and so on. These other fields could look to their own entry 
level competencies and evaluate the accuracy of the 
practitioners in the performance of their daily activities.
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Theoretical Framework
As part of the scientific revolution of the late 1800s 
and early 1900s, physician scientists took as assistants 
women who would aid them in the care of the laboratory, in 
the collection of specimens, and in the performance of 
certain simple procedures. By the 1920s, pathologists 
recognized that additional structured training was required 
of these personnel. As the degree of sophistication and 
complexity of the laboratory grew, these women took on more 
tasks, began making clinical decisions concerning the types 
and number of laboratory tests, modified older technologies, 
and created new ones. The first step of their nascent 
professional organization was to demand licensure as 
recognition as an independent profession.
The pathologist very much saw himself as a director of 
the strict scientific management structure with underlings 
who carried out the rules and regulations that the 
pathologists determined. Personnel in the laboratory 
regarded self-effacing responses to physician requests to 
embody the highest principle of professionalism. As changes 
in instrumentation and test complexity continued to develop, 
these personnel found themselves in yet another aspect of the 
clinical laboratory. They became managers. They hired and 
they fired. They determined the purchasing protocol. They 
determined the work flow and the needs of the laboratory. By 
the 1960s, they began to reassert their independence from the
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pathologist and the profession of pathology in a more 
strident fashion.
The desire for licensure as seen by the medical 
technologists, as they were then known, was the logical next 
step in the evolution of a profession. As these employees 
began to assume professional demeanor and authority, they 
grew less willing to remain subservient to pathologists who 
were no longer performing clinical testing but held authority 
over the performance of these tests. In response to this 
impasse over authority roles and responsibilities, the 
pathologists created a new category of personnel with a high 
school diploma and on-the-job training (clinical laboratory 
assistant or CLA) who performed the same procedures as the 
baccalaureate-educated staff. This attempt to lower 
standards and undercut the growing role of the clinical 
laboratory scientist ultimately failed due to the limited 
education that made them incapable of adequately addressing 
the changes in increased technology and sophistication in the 
laboratory.
The pathologists again chose not to acknowledge the 
separation of the profession of clinical laboratory science 
and proceeded to develop another level of personnel. This 
new third level of clinical laboratory personnel is called 
the clinical laboratory technician. In order to correct the 
earlier problem of inadequate basic science knowledge, the 
clinical laboratory technicians is required to be a graduate 
of a community college or military program.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
14
To repeat for emphasis, no one ever determined if 
personnel at this level are capable of providing accurate 
test results; the pathologists seated on the Board of 
Registry at the time simply included these competencies into 
the mix.
The content outlines for the two most well-known 
certification examinations, American Society of Clinical 
Pathologists (ASCP) and National Credentialing Agency for 
Medical Laboratory Personnel (NCA), contain requirements for 
accurate identification of peripheral blood white and red 
blood cells. The differences between the two levels of 
individuals are seen in knowledge of physiologic and 
pathophysiologic theories, management, budget preparations, 
problem solving, and evaluation. The content outlines and 
application material further inform the student that the 
associate level individual will be questioned at the recall 
and application level while the baccalaureate individual will 
be questioned at the recall, application, analysis, and 
evaluation levels (ASCP, 1980; NCA, 2000). It has just been 
assumed that there is no difference in test report accuracy 
between the two levels of personnel.
The combination of increased complexity and the changing 
face of organizational structure found more clinical 
laboratory scientists using team and motivational theories of 
management. Works by Maslow (1943) and Senge (1990) became 
known and their ideas practiced. Again, pathologists refused
♦“ /■*•> V* o ***✓"» *"3 1 £  4 W  » ft* o * ^r* / 1 01 C \
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The disharmony in the laboratory reflected the tensions 
between an authoritarian figure bound to the time-honored 
hierarchical approach and the employees practicing a day-to-
day management style more aligned with Senge. The late 20t*1
century's need for a cheaper medical delivery system 
strengthened pathology's desire for control and weakened the 
health care team concept.
What developed over the last 20 years was the archetypal 
struggle described by Fukuyama (1992) . Clinical laboratory 
scientists have struggled to take control of their 
profession, only to have hospital redesign and realignment in 
the wake of cost containment and managed care cause them to 
falter leading to an attempt at reestablishment of control by 
pathologists. The profession of clinical laboratory science 
needs to identify, by educational level, those persons who 
can perform minimum levels of acceptable results. This would 
provide a way by the members of the clinical laboratory 
science profession to establish control over the entry level 
into the profession.
As destabilization of the U.S. health care delivery 
system via cost-based analysis continues, it might also be 
prudent to evaluate if the lessening of education and 
training seen in the moves from physician to physician 
extenders such as physician assistants and nurse 
practitioners and from pharmacists to pharmacy technicians 
has had any impact on the quality of the care given to 
patients. Until that question is answered, this country may
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be at risk for decreasing quality of care in the name of cost 
containment.
This situation of emerging professions is seen in a 
variety of other health related situations. Mental health 
facilities employ master's degree level therapists rather 
than psychologists with doctorate degrees. As the profession 
of physical therapy tried to improve its quality by requiring 
additional education at the post-baccalaureate level, a new 
lower level of personnel, the physical therapy assistant, was 
created at the demand of hospitals and nursing homes. 
Operators of the pump oxygenator, also known as the 
heart/lung machine, are one of the few emerging professions
in the late 2 0 ^  century to achieve professional status,
thanks in part to the surgeons who recognized their 
importance and supported them in the recognition efforts.
At this level in the framework, there is a significant 
problem between the hierarchical philosophy of pathologists 
and the desire of the clinical laboratory employees, 
especially those at the baccalaureate level, to be recognized 
as an independent profession. One aspect of independence is 
the ability to set entry-level requirements of practitioners. 
In the past, those levels have been set with a proven 
arbitrariness by pathologists. To determine if these levels 
have any credence would begin to develop an answer to the 
fundamental question, "Is clinical laboratory science a 
profession?"
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No single study will answer this question. However, it 
is possible to evaluate each of the many aspects of this 
situation and determine if the data support the desire for 
independence. In addition, the patient public has a right to 
know if one of the most essential laboratory tests is 
performed by personnel who have been proven to provide 
accurate and consistent data.
Current Context
The organization of the clinical laboratory is 
consistent with the organizational systems of the beginning
of the 20t*1 century: a system of rules, boxes, and autocratic
control. Pathologists do seem to belong to the subset of 
scientific management theorists who believe that managers 
create a climate in which the prime effect is that they will 
remain in power (Taylor, 1916).
Rather than objectively reevaluating changing 
circumstances, decisions makers for the clinical laboratory 
chose to restructure and downgrade personnel issues in favor 
of increasing instrumentation and assembly line 
functionality. Increased productivity occurred but at a cost 
of disaffection and increasing frustration with the 
bureaucracy (Weber, 1946). This frustration has reached a 
significant point as the past decade has seen an almost
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universal choice of restructuring for efficiency as the 
preferred management tool.
Individuals looking for individual satisfaction and 
acknowledgement for work well done were stymied throughout 
the 1960s and 1970s, and, as a consequence, there was an 
attempt to wrest control from the pathologists by the 
formation of an independent certification agency. Attempts to 
supplant scientific management at the administrative level 
with either a motivational or teamwork approach has not been 
successful (Bennis, 1966; Maslow, 1943). Laboratory 
managers, like many other managers in the health care arena, 
use one or the other of these latter two approaches while the 
facility's administrators still use the scientific management 
approach.
Thus the chaos in hospital organization structure has 
not lessened as it has in other enterprises where competing 
philosophies and management systems have been eliminated 
(Senge, 1990). Unfortunately, neither philosophy has had the 
number of people in decision making roles to eliminate the 
other; the laboratory profession sits on the center point of 
a precarious seesaw.
Ever since the invention of the clinical laboratory 
technician in the late 1970s, there have been significant 
arguments concerning the scope of practice of clinical 
laboratory technician versus the clinical laboratory 
scientist. These discussions have occurred routinely at each 
of tils psst 20 yssns of simiisX CXi.ni.csX LsJoonstony Heines tons
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Conferences sponsored by the American Society for Clinical 
Laboratory Science. In each instance, no evidence is 
presented, only opinion.
It is the opinion of the clinical laboratory technician 
educators that CLTs should be performing the vast majority of 
procedures and that CLSs should be performing highly complex 
analyses, management, and education only. It is the opinion 
of the clinical laboratory science educators that this is not 
the case. They either keep silent in protest, knowing there 
is no evidence or cite anecdotal information concerning the 
difficulty in which CLT graduates find themselves when they 
elect to further their education by completing a 
baccalaureate degree. In the absence of evidence, 
assumptions and opinion carry the day.
When the field of medicine accepted the Flexner Report 
in 1910 as a call to self regulate its broad diversity of 
educational and experiential levels of training for 
physicians, there was no body of literature to support their 
activities, only the realization that something had to be 
done (Flexner, 1910; 1913). The same is true of nursing, 
social work, and other professional groups, which in the 
absence of externally imposed regulations, chose to define 
levels of practice and entry level competencies (Flexner, 
1915). In each of these situations, these groups were more 
free of interference from exogenous sources and were able to 
chart their own destiny. Clinical laboratory science is at 
the same place in its evolution as medicine was at the time
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20
of the Flexner Report and has the added burdens of 
pathologist control, hospital financial needs, and federal 
and state regulations.
There are thousands of laboratory tests and many tests 
have multiple methodologies. To test all of these would be 
impossible. To choose a smaller number would require that 
the chosen test or tests possess some combination of 
knowledge, skill, and technical abilities rather than a fully 
automated or single step procedure. In each laboratory 
speciality, it is possible to determine those few tests that 
possess both this level of knowledge, skill, and abilities 
and a level of criticality to patient care. In the 
hematology laboratory that test would be the complete blood 
count's differential.
With sufficient numbers of contributing personnel, it 
would be possible to determine if educational levels played a 
role in the accuracy of the peripheral blood differential.
The results of this study should have a profound effect on 
the educational structure and work force utilization of the 
clinical laboratory personnel. Facilities should then review 
the job descriptions and entry level qualification for all 
personnel who will be called upon to perform this test. This 
review, in turn, would cause further evaluation of any 
advancement pathways (career ladders) for those who work in 
the clinical laboratory.
While some European countries (e.g., Finland) have used 
a modification of the proficiency evaluation, the educational
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background of their laboratory professionals is quite 
different than that of the United States. Only one state 
Public Health Agency (Wisconsin) uses this method of 
evaluation, but it does not require any specific person to 
perform the test and only one report is expected from each 
laboratory. Putting the more precise testing situation 
together with the ability to group responders according to 
their education background has never been done.
Although this study could never be said to be 
definitive, its results provide the basis for additional 
testing in order to validate its conclusions. If these 
conclusions are validated, patients would have, for the first 
time, an objective method by which to determine the potential 
for accurate evaluations of their peripheral blood smears.
Another aspect of the current situation that would be 
impacted would be the educational process of both levels of 
personnel. Educators might revamp their curricula to support 
a new work paradigm by eliminating differentials from the 
associate degree curriculum. The National Accrediting Agency 
for Clinical Laboratory Personnel might also revise its 
Essentials For Accredited Programs to eliminate the 
performance of the peripheral blood differential as a 
required classroom objective.
If, on the other hand, there had been no statistically 
significant separation in accuracy, then baccalaureate 
programs could move away from routine testing in favor of 
newer or more sophisticated testing and management.
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Employers would also take the opportunity to restructure 
their pay scales according to the work performed.
Assumptions, Delimitations, and Limitations
The proposed study was guided by these assumptions:
1. Participants were willing to cooperate in the data- 
gathering process. The invitation letter to the program 
suggested that not all students were required to become 
involved in the process. Further, to prevent a faculty 
member from using these differential as part or all of a 
student's grade, the faculty members were not given the known 
results of the blood smears and the smears themselves were 
sent to the program after the completion of the didactic 
hematology course.
2. Data gathering was value-free and unbiased. All 
communication between the participants and the author was to 
be filtered by the faculty member on site. No names or other 
identifying marks were put onto the reports so that no 
potential for prejudice was possible. The background 
information on ethnicity and age was used to describe the 
participants but that information was on a separate sheet of 
paper so again, prejudiced evaluation of the results was not 
possible.
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3. Data gathering instruments yielded accurate and 
reliable information. While it could be possible to say that 
the instrument being used had been created for this purpose, 
it is also true that the instrument is a compilation of forms 
used nationally for this purpose and was critiqued by leading 
authorities in the field for its completeness and 
reliability.
The specific populations participating in this study 
came from a nationwide pool. They were between the ages of 
20 and 25 and had completed at least one didactic course in 
hematology at their institution but had not experienced a 
clinical rotation in a hematology laboratory. Traditionally, 
clinical laboratory science is a field in which women are the 
majority; therefore, a gender shift was noted. Also, there 
is a level of diversity that does not completely reflect the 
national breadth of ethnicities. Although there was a concern 
that associate degree program students may be a little older 
than their baccalaureate counterparts, this was not the case.
One of the limitations of this study was the 
willingness of participants, specifically the associate 
degree level students, to undertake a project that might 
adversely limit their career growth. Clinical laboratory 
technician programs have been expanding in the last several 
years as cost-containment strategies have used this 
assumption to restructure the personnel levels in many 
facilities. For clinical laborator17 technician students, a
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negative outcome in this study could be seen to diminish 
personal career growth potential.
Another limitation was the lack of true randomness to 
the populations. The only way to address this issue was to 
invite all students in National Accrediting Agency for 
Clinical Laboratory Sciences approved schools to participate. 
As expected, there was sufficient antagonism to the study 
that only a few programs were willing to participate and 
fewer than 100% of the report forms were returned. In the 
interest of fair play, the proposed limit to the number of 
clinical laboratory science students was upheld, even though 
several additional programs offered to participate.
Yet another limitation was the time frame. The time 
between the completion of a didactic hematology experience 
and experience in a clinical facility was a few weeks, so the 
window of opportunity for participation was such that some 
facilities which had requested to participate could not 
complete the project in the proposed timeframe.
One important caveat to this study lies in its 
randomness. As with the study of medicine, the clinical 
laboratory is composed of four major specialties which 
require significantly different knowledge, skills, and 
abilities. It is possible that, through the randomness of 
the selection process, the clinical laboratory technicians 
who participated were simply not as competent in hematology 
than they are in clinical chemistry or immunology or 
microbiology. The small number of participants may have
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unjustly inflated the significance of the differences 
measured.
Finally, it was important to limit the level of 
difficulty found in these various differentials. Throughout 
their existence, clinical laboratory technician programs have 
stated that their graduates should not be performing complex 
or highly abnormal differentials; their graduates should 
perform normal differentials only. This statement directed 
the choice of blood smear differentials into the more common, 
less fulminant presentations. This study sought to test only 
one de facto assumption about the currently installed base of 
skill sets as it relates to actual scientific and medical 
information provided. This is a situation in which a social 
context has been implemented with no proof and can only be 
examined by the development of a body of scientific and 
educational evidence.
Given the totality of assumptions, delimitations, and 
limitations, it was possible to derive valid data from this 
study to indicate the importance or lack thereof of 
additional examination of the differences in skill levels 
between clinical laboratory technicians and clinical 
laboratory scientists.
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Definition of Terms
The majority of terms used throughout the study are part 
of the daily language of a clinical laboratory professional. 
These terms are included in order to provide a common 
language set to be used in the course of the study. The 
definitions are taken from Clinical Diagnosis by Laboratory 
Methods and Management (Henry, 1998) .
Blood count (BC) - a determination of the number of formed 
elements in a measured volume of blood, as in red blood 
cell count, white blood cell count, or platelet count. 
Clinical laboratory scientist (CLS) - a person with a
baccalaureate degree in medical laboratory science and 
successful completion of a nationally-recognized 
certification examination.
Clinical laboratory technician (CLT) - a person with an
associate's degree in medical laboratory science and the 
successful completion of a national recognized 
certification examination.
Clinical laboratory assistant (CLA) - a person with a high 
school diploma and successful completion of a 6 month 
training program in a hospital. This title is no longer 
used.
Complete blood count (CBC) - Dependent on the specifics of 
the instrument involved, this is a collection of blood 
counts that includes the red blood cell count,
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quantification of hemoglobin, hematocrit or packed red 
cell volume (PCV), red blood cell indices, white blood 
cell count, platelet count and platelet indices, and the 
peripheral blood differential. If the differential is 
not included in the report, the results are termed the 
hemogram.
Differential - the identification and qualitative evaluation 
of peripheral white blood cells. Typically performed by 
counting 100 white cells smeared onto a glass slide, 
stained with a traditional Romanowsky-based stain, and 
viewed under a microscope, the actual number of cells 
will vary according the white cell count. If a patient 
has a severely decreased white blood cell count, fewer 
than 100 cells will be evaluated on the smear while more 
than 100 cells will be counted on a smear from a patient 
sample in which there is an increased white cell count.
Hematology - the study of the formed elements of the blood 
and their relation to disease.
Hematocrit - the determination of the percentage of whole 
blood that is made up of red blood cells as determined 
by centrifugation or other separation technique.
Hemoglobin - the oxygen carrying protein found in red blood 
cells.
Hemoglobin test - the quantification of the weight of 
hemoglobin found in 100 mL of whole blood.
Platelet count - the measurement of peripheral blood 
platelets in one liter of whole blood.
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Platelet indices - the measurement of the mean platelet
volume (MPV) and the platelet distribution width (PDW) 
in a given platelet population.
Red blood cell count - the measurement of the number of 
erythrocytes in one liter of whole blood.
Red blood cell indices - the measurement of the average size 
(mean corpuscular volume or MCV), the average weight of 
hemoglobin per average red cell (mean corpuscular 
hemoglobin or MCH), the percentage of volume used by 
hemoglobin in the average sized cell (MCHC) and the 
coefficient of variation in the size of the red cells in 
a given population (red cell distribution width or RDW).
White blood cell count - the measurement of the number of 
nucleated cells in one liter of whole blood. For the 
normal patient, the number of nucleated cells is equal 
to the number of white blood cells in the stated volume. 
However, for patients with specific conditions, 
nucleated red blood cells may be present in the 
peripheral bloodstream. It is therefore possible to 
have a falsely elevated white blood cell count by the 
inclusion of the abnormal red blood cells. In this 
instance, a correction of the white blood cell count 
would be required.
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Hypothesis
The choice between the use of a problem statement and a 
null hypothesis was one of potential interpretation. To use 
the question "Is there a difference in the quality of 
results?" implies that there could be subtle differences that 
could be statistically significant but are not clinically 
significant. To use the sentence, "There is no difference in 
the quality of results" requires a higher level of 
sustainable evidence. Given the potential impact that this 
study could have, it was determined that the stronger 
statement requiring more evidence in its favor was the 
preferred model.
The null hypothesis states that there is no difference 
between the competence of an entry level clinical laboratory 
technician and an entry level clinical laboratory scientist 
in the performance of a peripheral blood smear differential 
as evidenced through a comparison of the results of 
arithmetic means, chi square test, and other appropriate 
statistical tools.
Evidence of this shall include the following:
1.0 correlation to the consensus report of
1.1 polymorphonuclear neutrophils and bands
1.2 granulocytes and lymphocytes
1.3 lymphocytes and reactive lymphocytes
1.4 eosinophils
1.5 basophils





1.9 blast forms (myeloid, lymphoid, and erythroid)
2.0 correlation to the consensus report of
2.1 red cell morphology
2.2 nucleated red blood cells
3.0 correlation to the consensus report of
3.1 red cell inclusion bodies
3.2 white cell inclusion bodies




Results from the clinical laboratory are considered 
essential information for the diagnosis, treatment, and 
prognosis of patients. It is important that all laboratory 
results be as accurate as possible. The utilization of 
personnel with multiple levels of education to perform the 
same tasks calls to question either the accuracy of the test 
result or the proper use of trained personnel. This study 
provides a baseline for investigation into one or the other 
of these potential causes.
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CHAPTER 2: REVIEW OF THE LITERATURE
Introduction
A review of the history of clinical laboratory science 
as a profession is important in order to demonstrate the 
degree of control that one profession exerted over the entry 
level qualifications of another field. That pathologists 
arbitrarily defined minimum entrance levels into this 
profession without any justification or assessment resulted 
in the confusion of roles and responsibility in today's 
clinical laboratory science practitioners.
In order to clarify the procedures used in the clinical 
laboratory to assess proficiency and to ground the proposed 
study in the milieu of those methods, an explanation of 
concepts of quality control and proficiency is presented.
By 1968, quality control was seen as a process that 
viewed and reviewed the day-to-day consistency in the 
performance of an individual procedure while proficiency 
testing was seen as an external test of accuracy (Bauer, 
Ackermann & Toro, 1968, p. 2). Several variables, each one 
as important the others, are involved in this process. The 
most obvious one is the sensitivity and specificity of the 
procedure and its attendant instrumentation. Equally 
important are the abilities of the person who is performing
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the test while a third is the quality of the specimen. 
Another is the accuracy and clarity by which a report is 
transmitted or communicated.
History of Clinical Laboratory Science in the United States
Entrance of Women into the Scientific Process
While not considered in this work as a variable for the 
performance of peripheral blood differentials, an 
investigation into the historical bias concerning women in 
the scientific workplace could be of interest. At present, 
approximately 80% of the personnel in clinical laboratory 
science are women, while less than 15% of pathologists are 
women (Kotlarz, 1999b).
In colonial times, it was believed that women were 
destined for marriage and motherhood so they were taught 
enough to be able to prepare their sons for responsible 
citizenship (Rudolph, 1962). Even after the Civil War, it 
was expected that college-educated women interested in 
science would participate in amateur scientific societies or 
engage in observations in botany, zoology, and other fields
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(Glazer & Slater, 1987). Women who graduated from the few 
colleges and universities that accepted them found their 
opportunities for employment limited by a highly segregated 
and usually subordinate labor market in which they were 
confined to special female-designated or "sex-typed" fields 
that evolved as a consequence of changes in the nature of 
scientific work (Glazer & Slater, 1987). The availability of 
large amounts of money supporting "big science" required many 
assistants to work at newly established research centers. 
Subsequently, the development of new technologies and a 
growing concern over the nation's social problems gave rise 
to several new hybrid professions or semiprofessions, which 
created new roles for women.
Clinical Laboratories at the Turn of the Century
In 1919, the American College of Surgeons developed a 
plan for standardizing hospital organizations to assure 
minimum standards of care. Included among these were 
provision for the establishment of clinical laboratories. By 
1926, standards for accreditation required every hospital to 
have a clinical laboratory with a physician, preferably a
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pathologist, in charge. By 1925, nearly every hospital in 
the country reported having a laboratory (White, 1969).
As the workload grew, pathologists hired assistants to 
perform routine procedures for less money than the 
pathologist received for the same service (White, 1969). As 
early as 1912, female laboratory technicians held supervisory 
posts within the various departments of the clinical 
laboratory. The Accreditation Standards for the American 
College of Surgeons took these technicians for granted, 
requiring that clinical laboratory facilities be available in 
hospitals and that these laboratories should be in the charge 
of a trained technician (Sunderman, 1992) . Pathologists 
recognized that laboratory technicians were capable of 
performing many tasks in place of medical personnel.
Pathologists also recognized that these assistants had 
to be sufficiently competent to continue the work in the 
pathologist's absence yet not impinge on his authority. They 
found they could maintain their autonomy without losing 
control by encouraging a subtype of responsible 
professionalism among the higher ranks of subordinate health 
workers and by employing professionally trained women in 
auxiliary roles (Starr, 1982). Finally, some pathologists 
felt that having subordinates performing routine tests would 
elevate clinical pathology to a specialty status, thus
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protecting pathologists while relieving them of the routine 
testing (Starr, 1982).
One of the earliest descriptions of the work of a 
laboratory technician appeared in a 1927 book entitled 
Occupations for Women, edited by Lydia Hatcher. In this 
text, laboratory technicians are described as being 
"mechanicians" rather than scientists, particularly when the 
laboratory technicians possessed only a high school education 
and had received on-the-job training for the positions. They 
performed analyses and simple tests and reported the results 
of these tests to a physician, chemist, or some other 
scientist in charge. Most were employed by hospitals, public 
health agencies, and research facilities. They were rarely 
permitted to do anything beyond their routine duties because 
they lacked a college education or professional training that 
would have enabled them to fully understand the significance 
of their work and to grow through experience (Hatcher, 1927).
At the same time, another level of personnel was just 
beginning to emerge. This new "higher professional type" 
presupposed a minimum of 2 years of premedical course work at 
a college. Even as early as 1927, a bachelor's degree was 
preferred. Persons possessing this degree could advance to 
the professional supervision of a staff of assistants, while 
those who aspired to become chief laboratory technician were 
advised to earn a medical degree or Ph.D. in a scientific
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field related to the laboratory. In 1922, the University of 
Minnesota offered the first Bachelor of Science degree with 
the specialization in Medical Technology (Hovde, 1957).
Clinical Laboratory Science: 1930 through 1960
Between 1928 and 1945, clinical laboratory science 
became more widely recognized as an occupation distinct from 
pathology. Partially due to the explosion of tests being 
developed and the increasing reliance of physicians on the 
outcomes of the those tests and the increasing educational 
level of the technicians, the American Society of Clinical 
Pathologists (ASCP) reacted to these pressures by creating 
the Board of Registry (BOR).
When ASCP was established in 1922, one of the issues 
that confronted pathologists was the need to differentiate 
between technicians, whose work was primarily mechanistic and 
learned through apprenticeships, and pathologists, whose 
educational background was more extensive. Another source of 
concern was the widely disparate educational backgrounds, 
training, and experience of laboratory personnel and the 
absence of recognized standards that could be used to 
evaluate competence (Montgomery, 1970). Many institutions
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had developed training programs, unique to the needs of their 
own facility, to help alleviate the shortage of trained 
personnel. Because there was no mechanism for providing 
systematic instruction, each training program established its 
own standards. These ranged from the shortest period of time 
of 6 weeks to the longest of 96 months. Some were little 
more than experiences in indentured servitude while others 
provided lectures and formalized training sessions.
Some pathologists, notably Dr. Kano Ikedo, supported the 
development of a method to register qualified technicians by 
a central agency and the establishment of a national society 
for these technicians. He believed the laboratory 
technicians should be recognized as professional and that in 
achieving this goal, both the quality of laboratory services 
and the status of clinical pathology would be improved 
(Ikedo, 1940). Not all pathologists agreed. They were 
afraid that formalized education, registration, and 
professional status would be costly and these technicians 
might want to usurp the pathologist's functions and to 
unionize for higher wages. Further, they believed that no 
education was truly necessary since the technicians did not 
require knowledge of fundamentals in order to do their jobs 
(Ikedo, 1940).
Ultimately, ASCP agreed that the control of laboratory 
training would continue their control of the personnel and
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would regulate "diploma mills" in the manner used by the 
American Medical Association. In 1926, four pathologists 
were appointed to serve on the "Committee on the Registration 
of Technicians." The committee was charged to define and 
classify laboratory technicians and to establish a bureau to 
register laboratory technicians who met the standards and 
qualifications set forth by this bureau (Arens, 1952).
In 1928, the Committee on the Registration of 
Technicians (as cited in Montgomery, 1970, p. 435) reported 
their findings and six recommendations:
"1. To establish the minimum standard of
educational and technical qualifications of 
various technical workers in the clinical, 
research and public health laboratories;
2. To classify them according to these standards;
3. To receive applications for registration and 
issue certificates of registration to those 
who meet the minimum standards of 
requirements;
4. To register schools which offer an acceptable 
course of laboratory training;
5. To conduct a placement bureau for registered 
technicians; and
6. To cultivate a high ethical standard among 
laboratory technicians in accordance with the 
code of ethics established by the American 
Society of Clinical Pathologists".
These recommendations were adopted and officially marked 
the establishment of the BOR. After surveying the variety of
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educational programs, the BOR made recommendations concerning 
college course content, the inclusion of technical training 
in hospitals approved by the BOR, and an examination was 
developed. The registration examination consisted of a 
didactic portion, a practical portion, and the testimony of a 
pathologist that the person evaluated the personal and 
psychological attributes of the individual and had been found 
to be of good moral character (Montgomery, 1970).
After the establishment of the BOR in 1939, a group of 
technicians, unwilling to be registered by an agency whose 
central premise was the maintenance of the pathologist's 
authority, developed their own professional society (the 
Association of Medical Technicians or AMT) and developed its 
own certification agency (Kotlarz, 1999a). This organization 
is still extant today and has steadfastly refused to work 
with any other clinical laboratory group. Its certification 
agency has identical education requirements to both of the 
other larger certification agencies (Kotlarz, 1999b).
In 1948, the practical examination by which one could 
prove that a candidate could actually perform clinical 
laboratory tests correctly was discontinued because the BOR 
found it inefficient. Educational requirements increased 
while the Pennsylvania Medical Society developed an 
assessment of the actual performance of clinical laboratory 
workers (Sunderman, 1975). During the time that the BOR
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raised education and technical expectations, two schools of 
thought developed concerning the purpose of this education. 
One group believed that it should be based on the same 
pedagogical principles as any other educational system; that 
is, both knowledge and independent judgment were required in 
the clinical laboratory. Another group of pathologists 
believed that the practice of medical technology was purely 
mechanical and required little thought (Arens, 1955).
The BOR played a significant role in shaping the 
clinical laboratory science profession through the mid- 
1950's. It developed standards for competence for entry level 
practitioners, established and upgraded requirements for 
education and training of students, and devised a 
registration process to evaluate graduates of training 
programs.
Clinical Laboratory Science; I960 through the present
With the ASCP-created BOR and Board of Schools (BOS) 
controlling entry into the medical laboratory, the 
practitioners formed the American Society of Medical 
Technologists (ASMT) in 1935. ASMT changed its name to the 
American Society for Clinical Laboratory Science (ASCLS) in
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1995. In the mid 1960s, ASMT believed that medical 
technologists, or as they were increasingly calling 
themselves "clinical laboratory scientists" (CLS), were 
independent health care professionals according to the 
traditional definitions defined by Abraham Flexner in 1915. 
ASMT successfully argued in court against ASCP's contention 
that, in order to remain certified by the BOR, a medical 
technologist must always work under the direct supervision of 
a clinical pathologist, thereby opening the way for an 
increase in private, commercial laboratories as competition 
to the hospital laboratory (Lindberg, Britt, & Fisher, 1987).
Possibly as a retaliation for this action and as a 
response to increased demand for trained staff engendered by 
the rapid advances in automation and variety of testing 
procedures, ASCP developed a second level of laboratory 
employee. Called the Certified laboratory assistant (CLA), 
this person received a post-high school certificate after a 
training period in a hospital facility. There was no 
requirement for any post-secondary didactic experience. The 
CLA was paid less than the medical technologist but performed 
the same tests (Differentiation among MT, MLT, and CLA 
expected capabilities at career entry, 1973).
As the difficulty level of even routine laboratory 
practice proved too much for the certificate level worker, 
the CLA was allowed to fade out of existence and yet another
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level of practitioner was invented by the BOR. This was an 
associate degree level worker called the medical laboratory 
technician (MLT), now called clinical laboratory technician 
(CLT). Again, as with the CLA, this level practitioner 
performed the same tests and received less pay than the 
bachelor's degree practitioner (Differentiation among MT,
MLT, and CLA expected capabilities at career entry, 1973).
An extensive survey of the literature suggests that no 
published study has ever been implemented to determine if 
either of these two classes (CLA and CLT) achieved the same 
level of accuracy as that achieved by the medical 
technologists in the 1987 Lunz study.
In the late 1970s, ASMT withdrew from the BOR and 
established its own certification agency, the National 
Certification Agency for Medical Laboratory Personnel (NCA) 
in the belief that a profession should control its own 
certification process (ASMT Minutes, 1977). While the scopes 
of practice and levels of responsibility of CLSs and CLTs are 
clearly differentiated on the basis of educational objectives 
and in the certification examinations, these distinctions are 
still not consistently maintained in clinical practice. It 
is doubtful that CLSs have the power to enforce this 
separation strictly for there has been no evaluation of the 
levels of proficiency demonstrated by these two levels.
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With the advent of managed care and cost control, many 
facilities that relied on bachelor level clinical laboratory 
scientists are now hiring clinical laboratory technicians.
At the same time, as cost cutting forced physicians to spend 
less time with their patients, the medical professional began 
to rely extremely heavily on the data generated by the 
clinical laboratory.
Yet, at no time has anyone compared the skill level of 
the associate level practitioner to that of the bachelor 
level practitioner. It is assumed, however, based primarily 
on competence statements from the various certification 
agencies (Castleberry, 1996) and the single paper (Lunz, 
Castleberry et al., 1987), which compares the accuracy of 
certified medical technologists to uncertified on-the-job 
trained personnel that both the CLS and the CLT perform their 
tasks with the same levels of accuracy.
Who Performs Proficiency Testing
From the beginning of clinical laboratories, patients 
have had to accept on faith that the values reported to their 
physicians were correct. Yet, assuring accuracy among the 
approximately 600,000 laboratory employees in the United
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States is a difficult task. Federal law has limited impact 
as the concept of health care is almost totally absent from 
the United States Constitution, making federal control over 
the nation's 171,000 laboratories difficult and indirect. 
Because of the interstate commerce provisions in the 
Constitution, however, federal mandates have been easier to 
apply to large facilities. So with the passage of the 
Clinical Laboratory Improvement Act of 1967 (CLIA '67), 
patients could at least be sure that the approximately 12,000 
interstate laboratories were staffed by personnel with 
minimum education and that the testing performed in that 
laboratory included specific quality control and proficiency 
testing (P.L. 90-174). While both of these quality 
parameters provide some information about the overall level 
of accuracy achievable in a laboratory, neither can make any 
claims about the accuracy of the individual performing a 
test.
Pathologists strongly opposed imposing quality control 
and proficiency tests, claiming that costs would be high 
enough to compromise patient care and that such controls were 
too expensive. Although costs did rise during this time, it 
was also a time of great expansion for clinical laboratories 
in three other major areas: (a) the range of tests made 
available at hospital sites instead of reference 
laboratories* (b) the significantly increased sensitivity of
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these tests, and (c) the increased availability of multi­
channel instruments capable of providing a predetermined set 
of tests to be performed on a given sample.
These economies of scale as well as the increased use of 
laboratory information by physicians more than offset any 
cost increase due to staff educational levels, time off for 
professional development, and quality control purchases. 
Personnel pay ranges did not significantly increase during 
this time, given that more tests could be done by a lesser 
number of people due to the level of automation and the 
ability of non-interstate laboratories to hire non-certified 
persons and train them on the job.
But CLIA '67 was not as effective in achieving higher 
quality laboratory results as its proponents had hoped. The 
number of laboratories that fell under this statute was too 
small (approximately 17,000) to effect a significant increase 
in quality, and the personnel regulations were too limited in 
their scope. Additionally, too many affected institutions 
had the departmental supervisor or senior person perform the 
proficiency tests in a manner different from that which was 
used for routine patient testing. Finally, for the 
hematology laboratory, there existed no acceptable method for 
proficiency studies for the peripheral blood differential. 
This test is performed by a single individual identifying and 
evaluating 100 white blood cells on a single slide. Red
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blood cells and platelets are qualitatively examined as well. 
Given the number of cells on a slide, it was thought 
impossible to develop a proficiency process for this 
procedure. Yet, the differential is the single most important 
hematological test performed.
CLIA '88, or Son of CLIA '67
By the middle of the 1980s, societal pressures were 
beginning to focus on the cost and benefit of health care. 
Medical care costs were continuing to increase at a rate far 
ahead of all other aspects of the economy, including defense. 
The federal government and its administrative insurance 
carriers instituted a form of price control called Diagnostic 
Related Groups (DRGs) as one attempt to control costs, but 
this pricing system concerned Medicare patients only and the 
costs not covered by the DRG system were simply built into 
the charges applied to non-Medicare patients, a practice 
known as cost shifting (Marmor & Blustein, 1994) .
As an example of how one person's experience can affect 
the outcome for the whole, the mother of Senator Barbara A. 
Milkuski (D-MD) became ill and had laboratory tests performed 
by a non-CLIA'67 approved laboratory. In compelling
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testimony before her colleagues at the Senate Labor and Human 
Resource Committee meeting on April 18, 1988, she argued that 
regulations needed to be applicable to all laboratories by 
recounting that faulty laboratory test results almost killed 
her mother. Her testimony among others turned the debate in 
Congress and CLIA'88 was passed. It made all CLIA '67 
regulations applicable to all clinical laboratories, unless 
those laboratories chose not to accept any federal health 
dollars (Medicare, Medicaid, CHAMPAS, etc.). Further,
CLIA'88 tried to develop a correlation between the complexity 
of the performance of a test and the qualifications of the 
person allowed to perform it.’
The intent of Congress was to ensure a level base of 
quality available in all clinical laboratories. Through its 
regulations, Congress sought to analyze the issues involved 
in laboratory testing by dividing the entire process into 
sections: preanalytical (patient preparation and 
identification, specimen collection, transport and storage), 
analytical (the performance of the test itself from sample 
utilization through instrument quality to results), and post- 
analytical (the significance of the result itself, the proper 
assessment of the clinical correlation of the result with 
other data and communication with the appropriate 
authorities). Congress wished to make sure that the more 
significant or difficult a test, the more well trained the
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person assigned to perform it (CLIA '88-Intent of 
legislation, 1988).
Between 1988 and 1992 when the regulations were first 
promulgated (Federal Register, December 6, 1992), a task 
force of the American Society for Clinical Laboratory Science 
(ASCLS), headed by Professor James T. Griffith of 
Massachusetts, developed a complexity model that was used to 
determine the educational and professional level of persons 
capable of performing specific procedures. In 1992, this 
model was submitted to the Centers for Disease Control and 
Prevention to be applied to all existing laboratory analyses. 
Subsequently modified by oversimplification, the model has 
not been as important as originally conceived.
Much of the pressure for modifications came from 
physicians who owned and/or operated private physicians' 
office laboratories and who believed that the increased 
federal government influence would be too expensive and 
overly burdensome (American Family Physician, 1989; Hurst, 
Nickel, & Hilborne, 1988). The data indicated that their 
office laboratories were not as well run as one might have 
assumed (Bloch, Cembrowski, & Lembesis, 1988) . Despite the 
concerns and attempts to avoid the regulations entirely, all 
laboratories, including physician office laboratories, 
applying for reimbursement to the federal government through 
any of its agencies must obey the regulations promulgated
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Although one of the more dire predictions, few physician 
office laboratories have closed because of federal 
regulations, although many have merged into larger and more 
complex facilities serving group practices (Crawley, Belsey, 
Brock, Baer, & Loshchen, 1986). Remarkably, as all of this 
change was swirling around it, the laboratory as a whole has 
remained one of the most regulated parts of the health care 
delivery system while its individual practitioners are some 
of the least regulated.
Scope of Proficiency Testing in the Clinical Laboratory
Proficiency testing is the accepted method by which 
laboratory results are compared to known values (Tholen,
1988) and has been deemed by CLIA '88 as a required method of 
quality assessment (Federal Register, March 14, 1994; May 14, 
1998; June 15, 1998; Morbidity and Mortality Weekly Report, 
March 8, 1996). Several studies have evaluated the 
statistical methods (Grannis, 1978; Lawson, 1995; Lawson, 
Gilmore, & Tholen, 1988; 1993). Two additional studies have 
reviewed the effect of storage and transport on aqueous
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samples (Hyvarienen, 1985; Jenny, 1994). Finally, studies 
have been performed to ascertain the effect of proficiency 
testing as a management tool (Castaneda-Mendez, 1992; Haven, 
1978). Since the early 1960s, proficiency testing has been 
accepted world wide in clinical and public health 
laboratories (Beeser, Nerten, Drescher & Fischer, 1975; 
DeClerq, 1988; England, Rowan, van Assendelft, Bull, Coulter, 
Fujimoto, Groner, van Hove, Jones, Kaneter, Klee, Koepke, 
Lewis, d'Onofrio, Tatsumi, & McLaren, 1998; Havelaar, 
Hogeboom, Sekhuis & van Erne, 1987; Rajamaki, 1980).
Proficiency Testing in the Clinical Chemistry Laboratory
Because their discipline is most closely allied to the 
concept of proficiency testing, clinical chemistry 
laboratories were the first to use such testing in great part 
due to the ease with which specimens could be aliquoted, 
stored, and tested (Miller, 1979) . At the time of 
proficiency testing's inception, clinical chemistry methods 
varied wildly, with no single method judged better than 
another, and with many home-grown modifications or methods 
available. It was common practice to have a clinical chemist 
on site whose responsibilities included the development of
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procedures for use in the laboratory.
These multiple and, at times, conflicting methods caused 
a major difficulty in the determination of acceptable ranges. 
For example, blood glucose was sometimes reported as all 
reducing substances (reference range: 80 -120 mg/dL) or as a 
combination of the three important similar sugars: glucose, 
fructose and lactose (reference range: 70-100 mg/dL) or as 
only glucose (reference range: 60-90mg/dL). A result of 
118mg/dL might be considered acceptable or unacceptably too 
high. Thus, method became the important criteria in 
assigning acceptable ranges(Ross, 1998; auBuchon, 1991). 
Sample preparation, in-house error, variability in instrument 
sensitivity and specificity all contribute to the 
difficulties in assigning acceptable ranges (Bennett,
Eckfeldt, Belcher, & Connelly, 1991; Ehrmeyer, Laessig, 
Leinweber, & Oryall 1990; Lawson, Williams, & Long, 1993; 
Mitchel & Doran, 1985).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
52
Proficiency Testing in the Microbiology Laboratory
The Centers for Disease Control and Prevention (CDC) 
initiated a national proficiency testing program in 
mycobacteriology through the use of lyophilized (freeze 
dried) samples (Griffin, Cook & Mehaffey, 1986; Griffin, 
Mehaffey, Cook, Blumer & Podeszwik, 1986). Proficiency 
testing for reportable organisms such as Mycobacterium 
tuberculosis (Morbidity and Mortality Weekly Report, August 
11, 1950) to nosocomial infections to food microbiology 
(Peterz, 1992; National Nosocomial Infections Study Report) 
is routine. Proficiency testing is required in the other 
subspecialty areas of microbiology: mycology, parasitology 
and virology (Eamsobhama & Boranintra, 1993; Smith, 1974; 
Wood, Palmer, Missett & Whitby, 1994).
Proficiency Testing in the Immunoloay/Seroloay Laboratory
While the serology laboratory uses similar specimens 
(serum, plasma, urine, etc.) with those of the clinical 
chemistry laboratory, its methods involving the use of 
monoclonal antibodies and ligand assays are sufficiently 
different to cause a unique set of problems (Francis,
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Peddecord, Ferran, Benenson, Hofherr, Garfein, Schalla, & 
Taylor, 1992; Haven & Lawrence, 1977). Thus, it is the 
testing methods again that pose a set of issues for 
proficiency testing in the serology laboratory.
Another set of issues involves the qualitative aspects 
of several of its test procedures. Pregnancy tests, for the 
most part, are positive or negative. Only in rare medical 
situations, such as hydatiform mole or certain malignancies, 
is it necessary to determine "how much" pregnant. In those 
circumstances, the sensitivity of the method, and the ability 
of the method to provide quantitative as well as qualitative 
results must be taken into account.
Finally, the immunology laboratory and its close cousin, 
the immunohematology or blood bank laboratory make 
significant use of red blood cells and white blood cells for 
testing. Once stabilized cell suspensions became a reality, 
these laboratories too could participate in proficiency 
testing (Ezer, Burnie, Carstairs, Ley, McBride, Pinkerton, 
1981; Goguel, Crainic, Ducailar & Quinn, 1993; Polesky & 
Hanson, 1990; Rickman, Monical & Waxdal, 1993).
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Proficiency Testing in the Cytology Laboratory
Although not usually included in the traditional 
clinical laboratory but more closely allied with pathology, 
cytology laboratories have a great deal in common with the 
hematology laboratory. Both laboratories use microscopic 
evaluation of cells that requires (a) knowledge of cellular 
structure, (b) reactivity to stains, and (c) quantitative and 
qualitative assessment of specific cell lines. Above all, 
the process is performed by a single individual who is 
examining the specimen. As a consequence, the cytology 
laboratory has issues and procedures similar to those in 
hematology (Collins, Kaufman & Albrecht, 1971; Haven, & 
Lawrence, 1978). Recent investigations have suggested that 
the use of Kodachrome slides are inferior to the use of the 
actual microscope slide examination for the assessment of 
proficiency (Hincklin, Plott, & Wood, 1981).
Studies in Canada, through the auspices of the national 
health care program (government of Canada), have proven the 
feasibility and success of using either Kodachrome slides for 
specific cell identification and actual cytology preparations 
for overall evaluation (Carney, 1984; Curry, Thompson, 
Dietrich, Lipa, Massarella, Taves, Wood & Zuber, 1987; DeBoy 
& Jarboe, 1991; Gifford & Coleman, 1994).
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Proficiency Testing in the Hematology Laboratory
Proficiency testing in hematology is a complex mixture 
of clinical chemistry-like analytes such as hemoglobin, 
function assays such as prothrombin time, and qualitative 
assessment such as peripheral blood differentials. Analytes 
for which there are standards available from the National 
Bureau of Standards and Technology are tested for in exactly 
the same manner that proficiency testing in clinical 
chemistry is performed (Mahoney, Wong, & Van Kessel, 1993). 
Similarly, coagulation testing based on the functionality of 
a specific or group of factors has been possible through the 
same stabilization process used in clinical chemistry for 
enzyme assays (Beeser, Nerten, Drescher & Fischer, 1975; Han, 
Lawson, Dodds & Lawrence, 1985).
Red cell, white cell, and platelet counts and accessory 
calculated results such as the hematocrit, MCV, MCH, MCHC, 
RDW, and MPV can be stabilized using the same method that 
commercial companies such as Bering, R&B Labs, CMSCoulter, 
and others use to provide daily quality control materials.
This left (a) the microscopic evaluation or differential 
and (b) the reticulocyte percent assay as the two major tests 
performed in the hematology laboratory without proficiency 
testing. The original and still more common method of 
proficiency testing is to provide Kodachrome slides of
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specific cells to be identified. This method is used by the 
College of American Pathologists Hematology & Clinical 
Resource Committee because it is inexpensive, consistent in 
duplication, easily stored or transported and has the 
advantage of retrospective evaluation after the final report 
has been received by the laboratory.
However, this method does not evaluate the ability of 
the laboratory practitioner to choose an appropriate site to 
evaluate or to identify cellular abnormalities within the 
context of an entire slide. Only a few services such as the 
Wisconsin State Laboratory Proficiency Testing Program 
provide such a method.
Supporters for this style of proficiency testing for 
differentials list disadvantages of the automated 
differential instruments (Spielman, 1968; Cornbleet, 1983; 
Lindenbaum & Nath, 1983; Knecht, Eichhorn & Streuli, 1985; 
Beris, Graf & Miescher, 1983). They cite the need for (a) 
the use of actual peripheral blood smears as the only 
legitimate method because the use of the smear requires the 
practitioner to identify the appropriate screening area, (b) 
to utilize the microscope to best advantage, and (c) to 
correlate the findings into a coherent report.
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The Finnish System
Beginning in the 1980s, the Finnish medical community 
adopted a system that relied on the complete specimen rather 
than the Kodachrome slide of individual cells. Based in part 
on the geography of a small country in which there were 
several large regional hospitals providing laboratory 
services to physicians' offices and rural facilities, the use 
of prepared glass slides was seen as an effective method.
This is in contrast to the United States' quality assessment 
service, which believed that the less breakable, more easily 
duplicated Kodachrome slides were a better choice for the 
over 500,000 hospital, physicians' office, and reference 
laboratories.
Anton Rajamaki was the medical officer in charge of 
developing and implementing a national proficiency program 
for Finland. As part of that national program, Rajamaki 
(1980) described an external quality control process to 
assess the performance of individuals in estimating blood 
cell morphology by bright light microscopy. The method is 
based on the application of a detailed result form to collect 
the results from the participants in a standardized manner 
and the application of a reference board of hematology 
experts to establish the morphological "truth" as correlated 
with the patient's condition and status.
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Eighty percent of the board must reach consensus for 
acceptance of a morphological detail as a "target finding" 
for the participants. For each proficiency testing survey, a 
score for mean percentage performance is calculated for each 
participant. This score indicates the percentage amount of 
correct identification of the "target findings" of the survey 
specimens and is an overall measure of performance of the 
individual. This method tests the quantitative and 
qualitative aspects of this procedure. No national 
methodology used in the United States does this. By choosing 
a consensus point of greater than 80%, mild or subtle details 
that could legitimately be missed in a routine setting are 
avoided.
Rationale for Study 
Introduction
To gain a proper perspective of the strengths and 
limitations of proficiency testing in the clinical 
laboratory, the ground on which the clinical laboratory was
built needs to be reviewed. By the end of the IS1"*1 century,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
59
rudimentary procedures were available to count blood cells, 
to measure hemoglobin and sugars (glucose is not the only 
one) in the blood stream. The concept of the clinical 
laboratory was controversial then, as it is now. Concerns 
were raised that laboratories were scientific luxuries, that 
they required too much space, that they were too expensive, 
and that the tests performed were too time consuming 
(Kotlarz, 1999a).
With the rapid advances in medicine during the first 4
decades of the 20til century, it became clear that standards
of laboratory medicine and personnel must be elevated in 
cooperation with medical societies, universities, and 
scientific institutions. Good intentions, however, did not 
become deeds until after World War II.
Initial Use of Proficiency Testing
One of the first issues addressed was the perceived 
inconsistency among laboratories. Physician directors would 
divide a specimen into multiple samples, send them to 
different clinical laboratories for analysis, and expect to 
obtain similar, if not identical results. More often than 
not, they obtained markedly different results. By 1945, a
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group of physician laboratory directors formed the Committee 
on Laboratories of the Pennsylvania Medical Society 
(Sunderman, 1972). Their early replicate testing revealed 
significant dichotomies among laboratories. In 1946, this 
committee organized the first anonymous testing system (Bulk 
& Sunderman, 1947) with an astonishing and sobering level of 
inadequate to grossly incorrect results from the tested 
facilities.
The College of American Pathologists (CAP) was also 
forming at this time and, due to the inclusion of many of the 
Pennsylvania pathologists on the initial Board of Directors, 
chose to apply this method nationally. These initial studies 
confirmed that validity of laboratory data can seldom be 
determined by mere inspection and that unsatisfactory 
laboratory work is prone to escape detection by those not 
fully qualified to pass critical judgment (Sunderman, 1975). 
As a result of these surveys, it became recognized that, to 
maintain high standards, the accuracy of measurements must be 
under constant professional surveillance.
CAP decided that the most efficient method with which to 
undertake this constant surveillance was the preparation of 
solutions whose concentrations were unknown to the analyst. 
Samples for clinical chemistry determinations were the first 
items for use since they could be made up in large batches, 
could be allocated into sealed ampules, and, most
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importantly, were stable enough to withstand transportation. 
Thus, proficiency testing for blood sugars, non-protein 
nitrogen, and other substances in the serum were born. 
Specimens for hematology, immunohematology, and microbiology 
were unavailable for some time due to the inability to find 
stable, transportable, and standard concentrations for 
testing samples. For these tests, either no proficiency 
tests or in-house samples for replicate testing were used.
Proficiency Testing Goes Formal and National
In 1949, the Virginia Pathology Society was the first to 
ask Sunderman to develop a monthly self-auditing proficiency 
testing service for their group. Some time after, the Alabama 
and Indiana Societies followed suit. For the next 36 years, 
the Sunderman Proficiency Testing Service provided to each of 
the participants in the service two ampules containing 
different sera or solutions which were received by the 
participating laboratories on the first day of each month. 
Results of the tests were then reported to the Service within
+* V"i48 hours of the sample's arrival. On the 15 day of the
month, participants received a report that included the 
results of a statistical analysis of the values reported by
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all the participating laboratories, a current review of 
pertinent methodology, a comprehensive bibliography, and 
validation of the results of that specific laboratory.
From its inception, all results were held in confidence, 
and every precaution was taken to avoid disclosing exact data 
without a specific request from the laboratory director.
When the results of analyses for the solutions of any given 
month fell outside allowable range of values, the directors 
of the laboratories were encouraged to take an understanding 
and constructive approach in their efforts to ascertain the 
causes for the inaccuracies and to bring about correction.
End of an Era and the Beginning of Another
In 1967, the National Bureau of Standards (now the 
National Institute of Standards and Technology) became active 
in the development of clinical standards for other clinical 
chemistry analytes. As physicians began to rely more and 
more on the steadied accuracy of the numerical data produced 
by clinical laboratories, and as patients began to realize 
the necessity of the accuracy of these data, an effort to 
obtain legislature to assure this accuracy developed. The 
pathologists' view was that legislation, rules, and
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regulations from governmental agencies were inordinately time 
consuming, undeniably wasteful, and excessively costly. The 
proponents believed that the public was at risk in the choice 
of laboratory in which their specimens were tested. In 1967, 
Congress passed the Clinical Laboratory Improvement 
Amendments to the Social Security Act.
Based in the Constitutional right to control interstate 
commerce, this federal law set minimal standards for 
professional education of personnel and requirements for 
proficiency testing for all laboratories that were engaged in 
the receipt of specimens from out-of-state facilities. For 
the most part, these requirements were active for private 
laboratories such as Smith Kline (now Smith Kline Beecham) 
and hospitals that served patients from states other than 
their own. Facilities (large or small) not engaged in 
interstate commerce were not included.
By the mid 1970s, the process of freeze drying had left 
the confines of the space program and was incorporated into 
the storage of bacteria. This process allowed 
microbiological samples to be transported to distant sites, 
reconstituted, and used for bacteriologic proficiency testing 
Griffin, Cook, & Mehaffey, 1986). Methods developed for 
quality control specimens to be used in multiparameter 
hematology instruments were also transformed into the 
processing of proficiency testing for the red blood cell
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count, white blood cell count, platelet count, and hematocrit 
(hemoglobin determination proficiency tests having been 
developed earlier through the use of aqueous standards 
similar to clinical chemistry analytes). With the 
stabilization and preservation of human cells having been 
accomplished, specimens for proficiency testing in the 
immunohematology and serology laboratories became available 
(Taylor, Fulford, Przybyszewski, & Pope, 1979) .
Summary
Clinical laboratory practitioners were conceived out of 
a need for accurate, reliable clinical data. Throughout the 
years, these individuals have been provided entry level 
qualifications at multiple levels without anyone ever 
determining if these levels were appropriate or provided a 
"value-added" concept of quality for the patient.
Proficiency testing methodology is the accepted method 
for ascertaining laboratory and interlaboratory consistency 
and, one hopes, accuracy. For the majority of analytes, the 
major weakness is the very essence of a proficiency sample 
for the sample is known to be a proficiency sample. Many 
laboratories prefer their senior scientists to perform the
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evaluation. In addition, it is possible to rerun the test 
multiple times in order to assure the most correct answer 
prior to reporting the result.
Both of these occurrences violate the essential 
assumption that a proficiency test must be performed in the 
same manner as all routine tests. This one weakness, 
however, is not sufficient to claim that proficiency testing 
is not worthwhile. Even with this limitation, significant 
numbers of laboratories through the years have proven 
themselves unable to attain the minimum level of proficiency. 
Proficiency testing is a cost-effective, consistent method to 
assess laboratory competence.
Clinical laboratory science has had an erratic history 
in its attempts to be recognized as a profession. Pressures 
by pathologists and hospitals added to the prejudice 
surrounding women in the scientific workplace have caused 
multiple educational levels, training experiences, and 
certifications to occur with little to no evidence of which 
gives the better quality result to the patient. While only a 
small step, perhaps this dissertation will stimulate interest 
in assessing the proficiency of the individual, not the 
facility.
A study was designed to evaluate the accuracy of CLS and 
CLT practitioners at entry level. Entry level practitioners 
were chosen in order to eliminate two variables. By
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restricting the study to entry level personnel, participants 
in each of the cohorts were at the same level of didactic and 
clinical laboratory experience. Second, because laboratories 
vary widely in their scope of practice (walk-in clinics to 
tertiary medical centers), the choice of entry level 
practitioners also eliminated the additional exposure and 
learning that occurs in the laboratory.
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CHAPTER 3: METHOD
Introduction
Ever since the invention of the clinical laboratory 
technician in the late 1970s, there have been significant 
arguments concerning the scope of practice of this level of 
practitioner versus the clinical laboratory scientist. These 
discussions have occurred routinely at the annual Clinical 
Laboratory Educators Conferences sponsored by the American 
Society for Clinical Laboratory Science. In each instance, 
no evidence is presented - only opinion.
Clinical laboratory technician educators argue that CLTs 
should be performing the vast majority of tests and that CLSs 
should be performing highly complex tests, management, and 
education only. Clinical laboratory science educators 
believe that this is not the case. They cite anecdotal 
information concerning the difficulty in which CLT graduates 
find themselves when they elect to further their education by 
completing a baccalaureate degree. There is no objective 
evaluation of the assumed competencies of these individuals. 
In the absence of evidence, assumptions and opinions carry 
the day.
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When the field of medicine accepted the Flexner Report 
as a call to self-regulate its broad diversity of educational 
and experiential levels of training for physicians, there was 
no body of literature to support their activities (Flexner, 
1913). The same was true of nursing, social work, and other 
professional groups, which in the absence of externally 
imposed regulations, chose to define levels of practice and 
entry-level competencies. Clinical laboratory science is at 
the same place in its evolution as medicine was at the time 
of the Flexner Report and has the added burden of federal and 
state regulations.
Proficiency Tests
There are thousands of laboratory tests, and many tests 
have multiple methodologies. To test all of these would be 
impossible. To choose a smaller number would require that 
the chosen tests possess some combination of knowledge, 
skill, and technical abilities rather than a fully automated 
or single-step procedure. In each laboratory speciality, it 
is possible to determine those few tests that possess this 
level of knowledge, skill, abilities, and a level of 
criticality to patient care. In the hematology laboratory
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the test that possesses these attributes would be the 
complete blood count's differential.
How, then, can one evaluate the accuracy of peripheral 
blood differentials when performed by different people with 
different levels of education and training and in a manner 
that does not lend itself to comparisons? The College of 
American Pathologists uses Kodachrome slides highlighting a 
single cell or single set of cells to identify (Sunderman, 
1975). These slides are easy to duplicate and distribute, 
have relatively good precision in color development, and 
allow for comparison of answers since only one cell or set of 
cells is available to identify.
But the deficiencies of this system include the fact 
that the person looking at the slides must focus on the 
specific cell shown as the only cell in the picture or the 
cell identified by an arrow. There is no way to test if the 
person being tested would find this cell or recognize it as 
something important. Additionally, and perhaps more 
importantly, there is no method to determine who actually 
looked at the slide or if reference materials or support was 
used. Since the average peripheral blood smear is looked at 
by one person and rarely, if ever, does anyone else see those 
cells, it is ludicrous to assume that a slide is evaluated in 
the same way. In most clinical laboratories, proficiency 
testing is performed by the most senior or most well-educated
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
70
person who has access to additional texts. Occasionally, 
that slide is passed around for everyone to see and express 
an opinion, but only one opinion is returned to CAP for 
j udgment.
A much more cumbersome but much more accurate method is 
to distribute replicate copies of the peripheral blood smear 
itself and to take steps to ensure that every person 
performing differentials in a laboratory perform the test. 
Those answers, then, would be forwarded for evaluation. 
Another refinement is to require the same time span for 
routine analyses to be used for the proficiency sample.
With sufficient numbers of contributing personnel, it 
could be possible to determine if educational levels played a 
role in the accuracy of the peripheral blood differential. 
Either answer would have a profound effect on the educational 
process, hiring practices, and advancement potential of the 
people who work in the clinical laboratory.
While some European countries (e.g., Finland) have used 
this technique of evaluation, the educational background of 
their laboratory professionals is quite different than that 
of the United States. Only one state public health agency 
(Wisconsin) uses this method of evaluation, but it does not 
require any specific person to perform the test, and only one 
report is expected from each laboratory. Putting the more 
precise testing situation together with the ability to group
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responders according to their education background has never 
been done.
Although a single study of this type could never be said 
to be definitive, its results would provide the basis for 
additional testing by others in order to validate its 
conclusions. If those conclusions were validated, the 
patient public would have, for the first time, an objective 
method by which to determine the potential for accurate 
evaluations of their peripheral blood smears.
Research Design
This study was designed to investigate any qualitative 
difference in the performance of peripheral blood 
differentials performed by baccalaureate degree clinical 
laboratory scientists and associate degree clinical 
laboratory technicians.
Participants at both educational levels in this study 
were tested after they completed their college courses in 
hematology but before they had any clinical experience, thus 
lessening the complication of experiential learning. Each 
participant received prepared smears on which to perform the 
procedure.
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In this correlational study, one cohort of students were 
in their 2nd year of a clinical laboratory technician 
program, having finished a didactic course in hematology and 
prior to their clinical laboratory experience. The second 
cohort of students were in their 4th year of a clinical 
laboratory science program, having finished a didactic course 
in hematology and prior to their clinical laboratory 
experience. These two cohorts of students completed a set of 
10 peripheral blood smear differentials. Results from each 
student were determined to be within the accepted ranges as 
defined by Rajamaki. These values were correlated to the 
level of education defined in the cohort.
The independent variable was the level of education 
completed by the participants. The dependent variable was 
the accuracy of the peripheral blood differentials achieved 
by these participants as compared to the predetermined 
results. The variables were discrete in that the participants 
came from two distinct, easily identifiable groups and that 
the results of the testing procedure were compared to 
predetermined values (Christensen, 1997).
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Sample
In order to determine if there is any correlation 
between accuracy in the performance of a peripheral blood 
differential and the individual's educational level, it is 
necessary that populations of practitioners at two different 
levels of education perform the procedure on the same 
peripheral blood differentials. These practitioners should be 
at parallel points in their educational careers in order to 
minimize experiential learning. As a consequence, the 
individuals involved in the study had completed their campus- 
based hematology courses but not yet begun their clinical 
practicum experience.
Two cohorts of students from clinical laboratory 
science and clinical laboratory technician programs were 
given a set of 10 peripheral blood smears on which to perform 
peripheral blood smear differentials. These results were 
assessed for accuracy against known values developed by the 
Rajamaki method. Once determined to be acceptable or 
unacceptable, the results were subjected to standard 
statistical tools of mean, chi square test, Pearson product- 
moment, and other appropriate tools.
There are over 500 programs in clinical laboratory 
science at the associate degree and baccalaureate degree 
levels (NAACLS, 1999). In an average year, approximately
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4,000 students graduate from these programs. To test all of 
them was impossible. Thus the issues of sample and sample 
size were resolved. In order to lessen the potential for 
local irregularities or colloquial usage, these participants 
were gathered from more than one state or region. Letters 
describing this study were sent to the directors of clinical 
laboratory science and clinical laboratory technician 
programs throughout the country soliciting volunteers.
It was also critical to this study that the participants 
be at parallel points in their professional education. 
Participants who are nontraditional by virtue of entering 
into a second career or by virtue of a late entry into a 
collegiate program and those who have experienced one of the 
United States military programs in clinical laboratory 
science would have altered the sense of "entry level" 
comparison necessary to determine the issues of educational 
attainment rather than individual expertise. It is fair to 
state that that only one CLT student out of the total of 37 
was old enough to be termed "nontraditional."
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Sample Size
Of the 500-plus programs, there are 288 programs in 
clinical laboratory science and 239 programs for clinical 
laboratory technicians. Between both levels, over 3,000 
students were graduated. The original Lunz study in 1987 used 
25 medical technologists and 25 nonregistered laboratorians.
This study proposed to use a total of 100 participants. 
The peripheral blood smears reviewed by a cohort of some 50 
clinical laboratory technician students; another cohort of 50 
clinical laboratory science students performed similar manual 
differentials on each of 10 peripheral blood smears. The 
students had just completed their final didactic and 
practical experiences prior to graduation so that they were 
as close to entry level competence as possible yet had not 
begun to practice, so that experience did not affect their 
judgments. Each used the attached result sheet (see Appendix 
B) in order to neutralize local area/hospital jargon.
Sample Diversity
The clinical laboratory scientist and clinical 
laboratory technician programs were chosen on a first reply
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basis with the caveat that they represented at least 3 
different states in order to minimize local area teaching or 
colloquial expressions or techniques. There was no 
requirement by the school that all of the students 
participate in the survey. Since programs vary in size, the 
number of individual programs was determined based on the 
number of students who chose to participate in the study.
Instrumentation
Ten replicate peripheral blood smears of 10 different 
case presentations were made, stained, and cover slipped 
prior to assessing that they met the criteria necessary for 
inclusion in the study. This post-processing assessment was 
important to assure that no cellular artifact had been caused 
and no important element lost during the processing. By 
using replicate peripheral blood smears instead of 
photomicrographs, the participant performed actions required 
for an accurate differential. Because of the small number of 
participants, it was important to provide multiple 
opportunities in order to diminish any statistical skew due 
to small sample size. Thus, each participant performed 10 
peripheral blood differentials.
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Validity and Reliability of the Report Form
Over a dozen different instrument manufacturers in the 
United States alone sell instrumentation for the CBC. Each 
one has its own basic report form. Each facility then 
tailors that report form to suit the needs or desires of the 
physicians using that facility. Because there is no single 
universally agreed upon report form for the CBC, and because 
local colloquialisms must be accommodated, the data 
collection device was a compilation of the most commonly used 
forms.
This reporting mechanism was understandable to any 
participant from any region of the country, but it would not 
have been used previously by any of the students by virtue of 
its length and comprehensiveness. Review and approval of the 
form was given by Prof. Bernadette Rodak of Indiana 
University (personal communication, April 17, 2000), Prof. 
Anne Stiene Martin of the University of Kentucky (personal 
communication, May 10, 2000), and Prof. Shirlyn McKenzie of 
the University of Texas Health Science Center at San Antonio 
(personal communication, April 29, 2000). Each of these 
university faculty are internationally known experts in the 
field of hematology and have written textbooks in the field.
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It was necessary to construct a form that was 
understandable to all participants. The base of the report 
form was taken directly from the computer report form used at 
the facility at which the peripheral blood smears were made. 
All differential requisitions use these terms in their 
reporting mechanism, although each facility may place them in 
different groupings, depending on the type of software or 
paper requisition form used.
In this study, it was important to use a much larger 
report form so that as many parochial issues of nomenclature 
as possible could be isolated. By using a form that included 
every known variant or presentation, the participant was not 
influenced to include or exclude elements. It was also 
important to expand an existing tool in order to prevent bias 
among those participants who may have used or not used a more 
commonly seen form. Additionally, since every participant 
used the same report form, there was greater ease in 
statistical analysis.
Peripheral Blood Smears
The ten patient presentations chosen reflect 
alterations in erythrocytes (red blood cells), leukocytes
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(white blood cells), and thrombocytes (platelets). These 
presentations accurately reflect the classic presentation 
of these cells in the respective disease/condition of each 
case. In order to protect patient confidentiality, not 
only were these smears made, stained, and initially 
evaluated at an institution not participating in this 
study, data concerning age, gender, admitting diagnosis, 
and the quantitative portion of the CBC were not provided. 
This data suppression proved to be a limitation in only one 
case in which the individual cell counts would have made 
the evaluation more precise. (See Appendix A for the 
complete analysis of each peripheral blood smear used in 
the study).
Nature of the Study
In order to discern if there were critical differences 
in the ability of laboratory employees educated at the two 
different levels of study, it was necessary to provide 
participants with the same material and ask that a routine 
peripheral blood differential be carried out. This study 
provided the correlation that has not been done in this 
field. It was not enough to simply discern if one cohort did
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better than the other; this study developed a body of 
evidence necessary to state whether there is or is not a 
correlation in the accuracy of differential examinations 
based on the type of education received.
Factors involved in the creation of the study included: 
number of participants, location of the participants, level 
of education which the participants have obtained at the time 
of the study, the quality of the material to be used, and the 
scope of the reporting mechanism.
Peripheral blood smears were made, stained, and cover 
slipped prior to assessing if they meet the criteria 
necessary for inclusion. By using replicate peripheral blood 
smears instead of photomicrographs, the participants 
performed actions that required for an accurate differential 
as would actually be experienced with a real patient 
specimen. This assessment after the sample processing was 
important to assure that no cellular artifact was caused and 
no important element lost during the processing. Because of 
the small number of participants, it was important to provide 
multiple opportunities in order to diminish any statistical 
skew due to small sample size. Thus, each participant 
performed 10 peripheral blood differentials.
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Procedure
Each participant used the report form seen in Appendix
B. All descriptors are widely used throughout the United
States and, where necessary, synonyms are available for use.
Each participant received one complete set of peripheral
blood smears and used their own or their program's microscope
for the procedure. By indirect means, the participants were 
encouraged to complete these smears within the time frame 
usually associated with routine work by paying each 
participant $10.00 for one hour's work. This amount of money 
was small to the individual yet provided an incentive and 
encouragement to finish within a reasonable span of time.
Rajamaki's method for differential proficiency testing 
achieved consensus on both cellular identity and qualitative 
aspects of those cells on the multiples of 10 peripheral 
blood smears used in the study. The consensus was performed 
by the clinical laboratory science hematology specialists at 
a hospital chosen because it is a teaching facility with an 
international reputation in hematology. None of the 
educational programs in the area is affiliated with it, 
lessening any chance of familiarity. Each specimen was 
chosen because it is a classic presentation of the disease 
state/condition of the patient. In this manner, there were 
likely to be no anomalous readings.
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Statistical Tools
Each participant's response was evaluated using the 
Rajamaki method to determine acceptability/non­
acceptability. These values then were examined using 
categorical data analyses such as arithmetic mean, chi 
square, Pearson's, continuity correction, and Mantel-Haenszel 
testing for linear association.
The first evaluation was to determine if the 
participant's results were within the accepted Rajamaki 
ranges. This was done by a comparison of the results to the 
mean and standard deviations listed in Appendix A. The 
second level of analysis determined if there was a pattern of 
correct/incorrect results.
Summary
This study compared the accuracy of results from 
peripheral blood differentials between two cohorts of 
clinical laboratory students in order to determine if there 
was a statistical significance in the quality of the results 
obtained by students finishing an associate degree curriculum 
and students finishing a baccalaureate degree curriculum.
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CHAPTER 4: RESULTS
Introduction
As result of the letters of invitation, four programs 
for clinical laboratory scientists and five programs for 
clinical laboratory technicians agreed to participate. The 
four baccalaureate programs were from Indiana, Massachusetts, 
Michigan, and Texas. The five associate degree programs were 
from Colorado, Hawaii, Illinois, North Carolina, and Rhode 
Island. At the outset, a total of 63 students in the 
baccalaureate programs and 47 students in the associate 
programs agreed to participate. By the end of the study, 51 
fully completed sets of data were returned by the clinical 
laboratory science students and 40 completed sets of data 
were returned by the clinical laboratory technician students. 
There was a 79.3% return rate for the CLS students and 85.1% 
return rate for the CLS students.
More than the four CLS programs were willing to 
participate. Because the first four programs to reply had 
more than a sufficient number of students; the others were 
told that the study was closed.
Because of the smaller student enrollment in the 
clinical laboratory technician programs, it was expected that
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more programs would need to be used in order to acquire the 
number of students originally intended. As anticipated in 
the study construction CLT students were less likely to be 
willing to participate. There were three types of replies 
among the communications received in response to the original 
letter of invitation (see chap. 1). The smallest number of 
replies indicated a willingness to participate. A slightly 
larger number refused without explanation, and the largest 
number refused, citing an attempt, as one writer put it, to 
sabotage a valuable career.
Description of Participants
The clinical laboratory science students ranged in age 
from 20 to 25. With the caveat that each participant self 
identified themselves according to the demographic rubric 
used in the study, the majority, 80%, were as white. Of the 
remainder, 16% were Hispanic, and 4% were black. The 
majority,82%, were female and 18% were male. Forty-seven of 
the participants had entered college immediately after high 
school. Of the four who did not, two entered the military 
but were not assigned to any clinical laboratory or medic 
experiences and two chose not to explain the delay.
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The clinical laboratory technician students ranged in 
age from 19 to 30 years of age. As with the first cohort, the 
majority, 62%, were white; 25% were Hispanic, and 8% were 
black, and 5% were other. Again, 28 participants entered the 
program immediately after high school. Of those who did not, 
four entered the program after marriage, three had worked in 
various jobs to save money for college, and two did not 
explain the delay.
It was anticipated that the combination of racial/ethnic 
and gender backgrounds would not reflect the nation; however, 
they seem to reflect the characteristics of this field.
Method of Evaluation
Preparation of the raw data for statistical evaluation 
was done in the following manner. First, the numeric white 
cell identifications were compared to the Rajamaki numbers. 
Item 1.0 of the hypothesis is performed by identifying the 
first 100 white cells seen on the peripheral blood smear 
after choosing a location on the smear that is deemed 
appropriate. Because the differential is based on a total of 
100 cells, relative increases or decreases in one cell line 
will cause perturbations in the other values. A value of one
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(1) was given to the quantitative white blood cell 
differential whose values fell within the Rajamaki consensus. 
A value of zero (0) was given to the quantitative white blood 
cell differential whose values fell outside of the Rajamaki 
consensus.
These white cells will have variations in their nuclear 
structure, cytoplasm size, inclusions, and granular numbers. 
These attributes are usually not included in the quantitative 
portion of the differential but are included in a section for 
comments. A value of one (1) was given to the qualitative 
white blood cell differential whose values fell within the 
Rajamaki consensus. A value of zero (0) was given to the 
qualitative white blood cell differential whose values fell 
outside of the Rajamaki consensus.
The examination of the red blood cell population is a 
qualitative one. The cells may vary in size, shape, color, 
and the presence of inclusions. A value of one (1) was given 
to the qualitative red blood cell examination whose values 
fell within the Rajamaki consensus. A value of zero (0) was 
given to the qualitative red blood cell examination whose 
values fell outside of the Rajamaki consensus.
The examination of the platelet population is also a 
qualitative one. The platelets may vary in size, shape, 
color, and the presence of inclusions. A value of one (1) was 
given to the platelet examination whose values fell within
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the Rajamaki consensus. A value of zero (0) was given to the 
platelet examination whose values fell outside of the 
Rajamaki consensus.
It was possible for a differential report to be 
unacceptable in one or more of these four aspects and still, 
by virtue of one category, provide the physician with some 
information that would be of clinical significance. Each 
report was evaluated for that clinical significance. A value 
of one (1) was given if the clinical significance of the 
overall evaluation was reported. A value of zero (0) was 
given if the clinical significance was incorrect.
Thus, each report was evaluated against specific and 
different criteria a total of five times. What follows is a 
report of the level of accuracy as compared against the five 
categories achieved by the individual cohort for each slide.
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Reports of the Individual Peripheral Blood Smear Examinations
Slide 1025
As described in Appendix A, chronic myelogenous leukemia
has a wide array of immature while blood cells and rare
(infrequent, not abnormal or unusual) nucleated red blood
cells to be identified. More CLS students than CLT students
correctly identified the white cell variants present. The
CLS students were more likely to find and over-report
spurious cytoplasmic anomalies than CLT students; thus only
75% of the CLS students correctly reported the qualitative
0aspects of the white cells while 97% of the CLT students did.
The red blood cell examination was correctly described 
by fewer of the CLS students than CLT students. The major 
discrepancies for the CLS students were in estimating the 
degree of frequency while the CLT students more frequently 
did not report the presence of a red cell abnormality. Over 
one half of the CLT students did not complete the platelet 
examination or, if they did, they chose not to report it 
while all of the CLS students did complete and report their 
observations.
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Clinically significant alterations were noted in four 
categories (white cell numbers, white cell quality, red cell 
quality, and platelet estimations). These were provided by 
more CLS students than CLT students.
Slide 2641
As described in Appendix A, chronic lymphocytic leukemia 
is characterized by the absolute increase of mature, 
monotonous looking lymphocytes with essentially normal 
appearing red cell and platelet populations. More CLS 
students than CLT students correctly identified the white 
blood cells. More CLS students than CLT students correctly 
described the qualitative changes such as toxic granulation 
seen in these cells. Because white blood cells tend to be 
distributed in an uneven pattern based on their adhesion and 
motility attributes, the only way that someone could have 
reported an incorrect numerical answer for the white cells 
would have been to have chosen an incorrect area of the slide 
to view.
Approximately the same percentages of CLS students and 
CLT students correctly described the red cell population. As 
with the first slide, the CLS students had a tendency to over 
call small and essentially unremarkable changes in the cells
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while several CLT student did not report the red cell 
description. The platelet estimation was correctly reported 
by most of the CLS population and fewer than half of the CLT 
students. Whether due to a failure to report their findings 
or a failure to evaluate the platelet population is unknown.
Clinically significant alterations were noted in two 
categories (white cell numbers and white cell quality) and 
were provided by more CLS students than CLT students. 
Additionally, several CLT students incorrectly identified 
cells found only in acute leukemias. This information, if 
reported, would have constituted a serious error, causing 
the physician to perhaps misdiagnose an indolent malignancy 
with a preferred "watch and wait" form of treatment as a 
condition requiring immediate, expensive, and dangerous 
chemotherapy and potential bone marrow transplantation.
Slide 3037
As described in Appendix A, megaloblastic anemia is 
characterized by the presence of significant numbers of 
larger than normal red cells with an oval rather than 
biconcave appearance. Adequate to decreased numbers of 
platelets and white cells are common. A specific white cell, 
polymorphonuclear neutrophil, frequently displays an aberrant
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nuclear form called hypersegmented. The three major criteria 
for the diagnosis of a megaloblastic anemia are macro­
ovalocytes, basophilic stippling, and hypersegmented 
polymorphonuclear neutrophils.
All of the CLS students and half of the CLT students 
correctly identified the white blood cell portion of the 
differential. Of the cells misidentified, 4 of the 37 CLT 
responders reported seeing very immature cells that do not 
belong to the neutrophil family.
All but one CLS student correctly described the red cell 
population. That one student did correctly describe the cell 
type but incorrectly assessed its frequency. Approximately 
one half of the CLT students failed to describe the red cell 
population correctly. While every one of the CLS students 
correctly assessed the platelet population, only 29% of the 
CLT students commented on them at all and all were correct.
Clinically significant alterations were noted in three 
categories (white cell quality, red cell quality, and 
platelet estimations). These were provided by more CLS 
students than CLT students.
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Slide 4599
As described in Appendix A, the peripheral blood 
differential from a patient with no spleen is characterized 
by the presence of increased mature neutrophils, occasional 
immature granulocytes, significant alterations in the size 
and shape of the red cells, and adequate to increased 
platelet numbers. The sine qua none feature of status post 
splenectomy is the presence of Howell Jolly bodies which are 
remnants of nuclear material. Frequently nucleated red blood 
cells are seen.
Most CLS students correctly identified the white blood 
cells and the subtle changes in the granulation of the 
neutrophils, while half of the CLT students correctly 
identified the white blood cells in the sample. Almost no 
CLT students noted the qualitative changes present.
Twice as many CLS students as CLT students correctly 
noted the presence of Howell Jolly bodies and nucleated red 
blood cells. All CLS students noted the appropriate comments 
for the platelets while only 48% of the CLT students did. 
Again there was significant numbers of responders who did not 
note anything in this category.
Clinically significant alterations were noted in three 
categories (white cell quality, red cell quality and platelet
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estimations). These were provided by more CLS students 
than CLT students.
Slide 5797
As described in Appendix A, a leukemoid reaction has 
striking similarities to chronic myelogenous leukemia. The 
major differences are in the absence of increased numbers 
of progenitor cells such as myeloblasts, typically normal 
appearing red cells and essentially unremarkable platelets. 
Qualitative changes in the neutrophils include changes in 
the granule number and character as well as the presence of 
an inclusion known as a Dohle body.
Almost all of the CLS students correctly identified the 
white blood cells and their qualitative changes while fewer 
CLT recognized the cells. In one instance of unexpected 
results, all of the CLT students did report qualitative 
changes.
All CLS students noted that the red cell population was 
within normal range, while only 83% of the CLT students 
agreed. Those finding abnormal red cells noted cells 
typically seen in chronic myelogenous leukemia. Again, 
fewer than 50% of the CLT students correctly identified 
this portion of the report while the majority of CLS 
students did.
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Clinically significant alterations were noted in two 
categories (white cell numbers, white cell quality). These 
were provided by more CLS students than CLT students.
Slide 8924
As described in Appendix A, myelodysplasia is a 
condition in which the relative numbers of abnormalities fall 
somewhere between acute leukemia and a leukemoid reaction. 
More CLS students than CLT students correctly identified the 
white cells. As one of the hallmarks of this condition is 
the presence of qualitative disturbances in the granulation 
of the neutrophil series, it is important that these changes 
be identified. Eight out of 10 CLS students identified these 
changes while only half of the CLT students did so. In 
addition, the CLT students reported cells that are only seen 
in lymphocytic diseases such as lymphoma, which have no 
connection with myelodysplasia.
Changes in the red cell population were identified 
correctly by more CLS students than CLT students. About one 
half of the incorrect results provided by CLT students 
concerning platelet estimations were no notation given.
Clinically significant alterations were noted in each of 
four categories (white cell numbers, white cell quality, red
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cell quality, and platelet estimations). These were provided 
by more CLS students than CLT students.
Slide 81902
As described in Appendix A, the response to an acute 
bacterial infection is characterized by a stress reaction 
seen in the white cells and platelets. Although the percent 
correct for the CLS students was less than other comparisons, 
more CLS students than CLT students correctly identified the 
cells. Twice as many CLS students than CLT students 
identified the changes seen in a stress reaction.
Fewer CLS students than CLT students correctly described 
the red cells. In most instances, from both cohorts, there 
appeared to be a trend toward overcalling the frequency of 
the abnormalities rather than not seeing or misidentifying 
them. Platelet estimates were correct for both groups.
Clinically significant alterations were noted in each of 
two categories (white cell numbers and white cell quality). 
These were provided by more CLS students than CLT students.
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Slide 80506
As described in Appendix A, the blood smear from a 
patient with HIV infection has decreased lymphocytes with 
significant alterations in red cell morphology and decreased 
platelets. More CLS students than CLT students correctly 
identified the number and quality of the white cells.
The red cell changes were identified by fewer of the CLS 
students than CLT students. Platelet assessment was performed 
correctly by all of the CLS students and fewer than half of 
the CLT students. There appears to be a consistent pattern of 
no-reporting of platelet estimations as those CLT students 
who performed the assessment were correct.
Clinically significant alterations were noted in each of 
two categories (white cell numbers and white cell quality). 
These were provided by more CLS students than CLT students.
Slide 9279
As described in Appendix A, compensated hemolytic anemia 
is primarily a condition involving altered red cells and an 
increase in platelets. The white cell population is 
essentially within reference ranges. More CLS students than 
CLT students correctly identified the normal white cells and
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the qualitative aspects of the white cells. More CLS 
students than CLT students correctly described the various 
changes seen in the red cell population and the platelet 
population. Comments concerning clinically significant 
alterations present in one category (red cell quality) were 
provided by more CLS students than CLT students.
Slide 9326
As described in Appendix A, microangiopathic anemia is 
another red cell population disorder. Accompanied by lesser 
changes in the white cells and platelets, it is the 
characteristic changes of the red cells that separate this 
red cell condition from others. More CLS students than CLT 
students correctly identified the white blood cells and 
changes in the white cell quality. CLT students noted the 
presence of abnormal lymphoid elements.
Nearly three times as many CLS students than CLT 
students reported red cell alterations. More CLS students 
than CLT students correctly reported the platelet assessment. 
Comments concerning clinically significant alterations 
present in each of four categories (white cell numbers, white 
cell quality, red cell quality, and platelet estimations) 
were provided by more CLS students than CLT students. See
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Table 1. for the summary comparison of percent correct 
reports for each evaluation performed on a peripheral blood 
smear differential.
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Table 1
Summary comparison of percent correct reports for each 
peripheral blood smear differential
Slid* WBC Q-WBC RBC FLT* Cl.Sig.
1025
CLS 82.35 78.43 43.14 78.43 72.55
CLT 51.35 97.30 62.16 27.03 48.65
2641
CLS 80.39 82.35 68.63 98.0 80.39
CLT 45.95 35.14 64.86 43 .24 29.73
3037
CLS 100 98.04 98.04 100 98.04
CLT 72.97 70.27 51.35 29.73 56.76
4599
CLS 92.16 94.12 92.16 100 100
CLT 51.35 5.41 43.24 43 .21 37.84
5797
CLS 96.08 96.08 100 100 96.04
CLT 72.97 100 83.78 48.65 72.97
8924
CLS 98.24 86.27 90.20 98.04 98.04
CLT 64.86 54.05 83.78 43.24 37.84
81902
CLS 74.51 90.20 72.55 100 70.59
CLT 35.14 40.54 86.49 100 43.24
9279
CLS 88.24 98.04 100 98.04 100
CLT 75.68 100 67.57 70.27 56.76
9326
CLS 86.27 100 88.24 100 96.04
CLT 54.05 72.97 24.32 62.16 40.54
Legend
WBC = Correct identification the white blood cell population
Q-WBC = Correct identification and frequency of any qualitative
anomalies present in white blood cells 
RBC = Correct qualitative description of the red cell
population
FLT = Correct estimate of the number of platelets
Cl.Sig = Correct assessment that provides meaningful information
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Overall Mean Result
A comparison of the mean levels of acceptable 
performance for all peripheral blood slides shows that CLS 
students were correct more often than CLT students through 
the entire procedure, even though there were a few instances 
of the reverse. In those instances, the CLS students were 
overcalling elements and finding alterations or concerns 
where none existed, while in the majority of situations the 
CLT students were missing or misidentifying cellular 
elements. (See Table 2.)
Table 2
Mean levels of acceptable performance for all peripheral 
blood slides
WBC Q-WBC RBC FLTa Cl.Sig.
CLS 90.22 90.61 84.10 95.20 90.63
CLT 63.49 62.16 73.15 55.25 50.00
Legend
WBC = Correct identification the white blood cell population
Q-WBC = Correct identification and frequency of any qualitative
anomalies present in white blood cells 
RBC = Correct qualitative description of the red cell
population
PLT = Correct estimate of the number of platelets
Cl.Sig = Correct assessment that provides meaningful information
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Statistical Evaluations of Correlation 
Introduction
Each peripheral blood slide was subjected to the same 
statistical processes for quantitative white blood cell 
accuracy, qualitative white blood cell accuracy, qualitative 
red blood cell accuracy and qualitative platelet accuracy.
All reports were analyzed first by the chi square method and 
then subject to the Pearson product-moment correlation with 
and without a continuity correction, a likelihood ratio, and 
Mantel-Haenszel test for linear association. Those results 
that had an expected value of less than 5 were subject to 
Fisher one-tailed and two-tailed exact tests.
Chi Square Analysis
The chi square test was used to test whether a 
significant difference existed between the observed number of 
correct reports and an expected number based on the null 
hypothesis. Each differential result was compared to the 
Rajamaki range and given a value of 1 if correct or a value 
of 0 if incorrect. These values were then placed into the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
102
traditional chi square. As was seen in the raw percentages 
and will again be seen in the additional statistical methods, 
chi square analysis demonstrated significant difference 
between the two levels of clinical laboratory personnel in 
the performance of the 10 peripheral blood slide 
differentials.
In 46 out of the 50 evaluations, the CLS students 
demonstrated greater accuracy than the expected chi square 
value. CLS students were more accurate 9 out of 10 times in 
the category of quantitative interpretation of white blood 
cells. CLS students were more accurate 8 out of 10 times in 
the category of qualitative identification of white blood 
cells. CLS students were more accurate 7 out of 10 times in 
the category of qualitative interpretation of red blood 
cells. CLS students were more accurate 10 out of 10 times in 
the category of qualitative interpretation of platelets. 
Finally, CLS students were more accurate 10 out of the 10 
times in the category of qualitative interpretation of 
clinical significance.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
103
Table 3
Values of chi square analysis for the five evaluative areas
on each De ripheral blood smear.
Slide WBC Q-WBC RBC PLTS Cl.Sig.
1024 2.80908 4.89136 2.80908 24.41338 32.84976
2641 0.32378 22.41139 0.32378 38.01856 47.04603
3037 27.60959 14.04037 27.60959 50.86661 23.44652
4599 25.22514 68.78094 25.22514 38.01856 42.92058
5797 8.86541 1.48472 8.86541 33 .40071 15.55094
8924 0.80612 11.22346 0.80612 34.33881 39.18106
81903 2.46048 24.85973 2.46048 NA* 6.63291
80506 2.04015 62.73998 2.04015 18.28612 24.42625
9279 19.15220 0.7383 19.15220 14.04037 26.95495
9326 35.84291 14.2215 35.84291 21.65203 36.79104
Legend
WBC = chi square value for Che white blood cell population
Q-WBC = chi square value for any qualitative anomalies present
in white blood cells 
RBC = chi square value for qualitative description of the red
cell population
PLT = chi square value for qualitative description platelets
Cl.Sig = chi square value for an overall description that
provides meaningful information 
NA = both cohorts achieved a 100% accuracy in this category
on this peripheral blood slide.
Pearson Product-Moment Correlation and 
Continuity Correction Tests
The Pearson product-moment correlation demonstrates a 
relationship between the two variables, level of educational 
attainment and degree of accuracy achieved by each cohort in 
the identification of white blood cells and the qualitative 
interpretations of white blood cells, red blood cells,
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platelets, and clinical significance. The degree of freedom 
(df) was 1. The probability of observing a value was <0.05. 
This level of probability provides for a wider latitude for 
the potential of an incorrect evaluation because (a) the 
number of participants is small and (b) the potential does 
exist that those persons who report incorrect findings may in 
time be able to identify the cells and anomalies correctly. 
Statistical significance as determined by a value equal to or 
less than 0.05 was present in 9 out of 10 quantitative white 
blood cell evaluations; in 8 out of 10 qualitative white 
blood cell evaluations; in 5 out of 10 qualitative red blood 
cell evaluations; in 10 out of 10 qualitative platelet 
evaluations; and in 10 out of 10 qualitative assessments for 
clinical significance.
Quantitative White Blood Cell Evaluations
The degree of significance as represented by the Pearson 
product-moment correlation ranged from 0.00001 to 0.00183. 
When adjusted for the small sample by the continuity 
correction, the range was from 0.00004 to 20784. For slide 
3037, where the expected value for occurrence was less than 
5, the continuity correction was 0.00031. For slide 5797, 
where the expected value for occurrence was less than 5, the
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continuity correction was 0.0506. For slide 80506, where the 
expected value for occurrence was less than 5, the continuity 
correction was 0.00189. Thus, in all of the four instances 
the continuity correction supported an assessment that there 
was correlation between the accuracy of performance and the 
educational level of the two cohorts. See Table 4 for 
statistical values for quantitative WBC evaluations
Qualitative White Blood Cell Evaluations
The degree of significance as represented by the Pearson 
product-moment correlation ranged from 0.00000 to 0.39164. 
When adjusted for the small sample by the continuity 
correction, the range was from 0.00000 to 1.0000. For slide 
1025, where the expected value for occurrence was less than 
5, the continuity correction was 0.06125. For slide 3037, 
where the expected value for occurrence was less than 5, the 
continuity correction was 0.00060. For slide 5797, where the 
expected value for occurrence was less than 5, the 
continuity correction was 0.62132 For slide 9279, where the 
expected value for occurrence was less than 5, the continuity 
correction was 1.0000. In only one of the four instances did 
the continuity correction support an assessment that there 
was correlation between the accuracy of performance and the
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educational level of the two cohorts. See Table 5 for 
statistical values for qualitative WBC evaluations.
Qualitative Red Blood Cell Evaluations
The degree of significance as represented by the Pearson 
product-moment correlation ranged from 0.00000 to 0.09373. 
When adjusted for the small sample by the continuity 
correction, the range was from 0.00000 to 0.73597. For slide 
57 97, where the expected value for occurrence was less than 
5, the continuity correction was 0.01075. For slide 8924, 
where the expected value for occurrence was less than 5, the 
continuity correction was 0.56776. For slide 80506, where 
the expected value for occurrence was less than 5, the 
continuity correction was 0.22049 For slide 9279, where the 
expected value for occurrence was less than 5, the continuity 
correction was 0.00005. Thus, in only one of the four 
instances did the continuity correction support an assessment 
that there was correlation between the accuracy of 
performance and the educational level of the two cohorts.
See Table 5 for statistical values for quantitative RBC 
evaluations
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Qualitative Platelet Evaluations
The degree of significance as represented by the Pearson 
product-moment correlation ranged from 0.00000 to 0.00018. 
When adjusted for the small sample by the continuity 
correction, the range was from 0.00000 to 0.00060. For slide 
9279, where the expected value was 5, the continuity 
correction was 0.00060. Thus, in all of the four instances 
the continuity correction supported an assessment that there 
was correlation between the accuracy of performance and the 
educational level of the two cohorts. See Table 6 for 
statistical values for qualitative PLT evaluations
Clinical Significance Evaluations
The degree of significance as represented by the Pearson 
product-moment correlation ranged from 0.00000 to 0.01001. 
When adjusted for the small sample by the continuity 
correction, the range was from 0.00000 to 0.1848. For slide 
5797, where the expected value was less than 5, the 
continuity correction was 0.000031. Thus, in all of the four 
instances the continuity correction supported a correlation 
between the accuracy of performance and the educational level
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of the two cohorts. See Table 7 for statistical values for 
clinical significance evaluations.
Overall Pearson Product-Moment Correlation Evaluation
The Pearson product-moment demonstrated a significant 
difference between the CLS students and CLT students in the 
performance of 6 out of 10 quantitative white blood cell 
evaluations, 9 out of 10 qualitative white blood cell 
evaluations, 5 out of 10 qualitative red blood cell 
evaluations, 10 out of 10 qualitative platelet evaluations, 
and 10 out of 10 assessments for clinical significance. The 
continuity correction is a similar statistic although it is a 
more conservative tool than the Pearson product-moment and it 
also demonstrated significant difference between the CLS 
students and CLT students in the performance of 7 out of 10 
quantitative white blood cell evaluations, 9 out of 10 
qualitative white blood cell evaluations, 5 out of 10 
qualitative red blood cell evaluations, 10 out of 10 
qualitative platelet evaluations, and 10 out of 10 
assessments for clinical significance.
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Likelihood Ratios
The likelihood ratios again correlated the relationship 
between level of education and accuracy in the performance of 
the five sets of evaluations for the peripheral blood smear 
differentials. The degree of significance as represented by 
the likelihood ratio for the Quantitative White Blood Cell 
Evaluations ranged from 0.00001 to 0.12426. The degree of 
significance as represented by the likelihood ratio for the 
Qualitative White Blood Cell Evaluations ranged from 0.00000 
to 0.29441 with three comparisons out of 10 that could be 
considered random occurrences. The degree of significance as 
represented by the likelihood ratio for the Qualitative Red 
Blood Cell Evaluations ranged from 0.00000 to 0.57012 with 5 
out of 10 instances showing potential random results. The 
degree of significance as represented by the likelihood ratio 
for the Qualitative Platelet Evaluations ranged from 0.00001 
to 0.12426 and one out of the 10 comparisons was shown to be 
random. The degree of significance as represented by the 
likelihood ratio for the Evaluations of Clinical Significance 
ranged from 0.00000 to 0.00010 and there were no instances of 
statistically random results.
Again, as with the Pearson product-moment and the 
continuity correction, the Likelihood Ratio demonstrated a 
significant difference between the CLS students and CLT
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students in the performance of 7 out of 10 quantitative white 
blood cell evaluations, 9 out of 10 qualitative white blood 
cell evaluations, 5 out of 10 qualitative red blood cell 
evaluations, 10 out of 10 qualitative platelet evaluations, 
and 10 out of 10 assessments for clinical significance. See 
Tables 4 through 8 for specific results.
Mantel-Haenszel Test for Linear Association
The Mantel-Haenszel test for linear association also 
correlated the relationship between level of education and 
accuracy in the performance of the five evaluations for the 
peripheral blood smear differentials. The degree of 
significance as represented by the Mantel-Haenszel test for 
linear association between CLS and CLT students in the 
evaluation of the quantitative white blood cell evaluations 
ranged from 0.00001 to 0.12408. The degree of significance 
as represented by the Mantel-Haenszel test for linear 
association between CLS and CLT students in the evaluation of 
the qualitative white Bblood cell evaluations ranged from 
0.00000 to 0.39435.
The degree of significance as represented by the Mantel- 
Haenszel test for linear association between CLS and CLT 
students in the evaluation of the Qualitative Red Blood Cell
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Ill
Evaluations ranged from 0.00000 to 0.57155. The degree of 
significance as represented by the Mantel-Haenszel test for 
linear association between CLS and CLT students in the 
evaluation of the Qualitative Platelet Evaluations ranged 
from 0.00000 to 0.00019. The degree of significance as 
represented by the Mantel-Haenszel test for linear 
association between CLS and CLT students in the evaluations 
of Clinical Significance ranged from 0.00000 to 0.01044.
In summary, the Mantel-Haenszel test for linear 
association demonstrated a significant difference between the 
CLS students and CLT students in the performance of 7 out of 
10 quantitative white blood cell evaluations, 9 out of 10 
qualitative white blood cell evaluations, 5 out of 10 
qualitative red blood cell evaluations, 10 out of 10 
qualitative platelet evaluations, and 10 out of 10 
assessments for clinical significance. See Tables 4 through 
8 for specific results.
Fisher One Tailed and Two Tailed Examinations
For those situations in which the expected value in the 
chi square examination was less than 5, Fisher one-tailed and 
two-tailed exact tests were performed to ascertain a more 
complete appreciation of significance. These procedures also 
correlated the relationship between level of education and
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accuracy in the performance of the peripheral blood smear 
differentials numbered 3037 and 80506 in the category of 
quantitative WBC evaluations; 1024, 5797, 9279, and 9326 in 
the category of qualitative WBC; 5797, 8924, and 80506 in 
the category of qualitative RBC evaluations; and 5797 in the 
category of clinical significance. In each instance, the 
statistics reported a significant difference in the accuracy 
of the performance between the two cohorts. See Table 9 for 
specific results.
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Table 4.
Statistical Values for the Evaluation of Accuracy in the
Performance of the Quantitative White Blood Cell Category,











1024 0.00101 0.00227 0.00097 0.00108
2641 0.00077 0.00171 0.00171 0.00082
3037 0.00008 0.00031 0.00001 0.00009
4599 0.00001 0.00004 0.00001 0.00001
5797 0.00182 0.00506 0.00153 0.00194
8924 0.00003 0.00009 0.00001 0.00003
81903 0.00022 0.00051 0.00019 0.00024
80506 0.00050 0.00189 0.00001 0.00053
9279 0.12194 0.20784 0.12426 0.12408
9326 0.00137 0.00315 0.00137 0.00146
Table 5.
Statistical Values for the Evaluation of Accuracy in the 
Performance of the Qualitative White Blood Cell Category, 










1024 0.02699 0.06125 0.01662 0.02789
2641 0.00000 0.00001 0.00000 0.00000
3037 0.00018 0.00060 0.00010 0.00019
4599 0.0000 0.00000 0.00000 0.00000
5797 0.22304 0.62132 0.13661 0.22568
8924 0.00081 0.00189 0.00078 0.00087
81903 0.00000 0.00000 0.00000 0.00000
80506 0.00000 0.00000 0.00000 0.00000
9279 0.39164 1.00000 0.29441 0.39435
9326 0.00016 0.00064 0.00003 0.00018
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Table 6.
Statistical Values for the Evaluation of Accuracy in the
Performance of the Qualitative Red Blood Cell Category, using










1024 0.09373 0.14455 0.09254 0.09564
2641 0.56935 0.73597 0.57012 0.57155
3037 0.00000 0.00000 0.00000 0.00000
4599 0.00000 0.00000 0.00000 0.00000
5797 0.00289 0.01075 0.00091 0.00305
8924 0.36927 0.56776 0.37256 0.37200
81903 0.11674 0.19150 0.10927 0.11884
80506 0.08123 0.22049 0.03386 0.08298
9279 0.00001 0.00005 0.00000 0.00001
9326 0.00000 0.00000 0.00000 0.00000
Table 7.
Statistical Values for the Evaluation of Accuracy in the 
Performance of the Qualitative Platelet Category, using a df 










1024 0.00000 0.00000 0.00000 0.00000
2641 0.00000 0.00000 0.00000 0.00000
3037 0.00000 0.00000 0.00000 0.00000
4599 0.00000 0.00000 0.00000 0.00000
5797 0.00000 0.00000 0.00000 0.00000
8924 0.00000 0.00000 0.00000 0.00000
81903 NA NA NA NA
80506 0.00002 0.00005 0.00002 0.00002
9279 0.00018 0.00060 0.00010 0.00019
9326 0.00000 0.00001 0.00000 0.00000
NA - both cohorts achieved a 100% accuracy in this category.
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Table 8.
Statistical Values for the Evaluation of Accuracy in the
Performance of the Clinical Significance Category, using a df










1024 0.00000 0.00000 0.00000 0.00000
2641 0.00000 0.00000 0.00000 0.00000
3037 0.00000 0.00000 0.00000 0.00000
4599 0.00000 0.00000 0.00000 0.00000
5797 0.00008 0.00031 0.00001 0.00009
8924 0.00000 0.00000 0.00000 0.00000
81903 0.01001 0.01848 0.00985 0.01044
80506 0.00000 0.00000 0.00000 0.00000
9279 0.00000 0.00000 0.00000 0.00000
9326 0.00000 0.00000 0.00000 0.00000
Table 9
Results of Fisher one-tailed and two-tailed Exact Tests for 
those Peripheral Blood Slide Reports that had less than the 
Minimum Expected Frequency of 5.
Category Slide One-tailed Two-tailed
teat teat
quantitative WBC 3037 0.00008 0.00008
80506 0.00060 0.00060
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Interpretation of the Data
For 9 of the 10 peripheral blood smear reports for 
quantitative white blood cell examination, the Pearson 
product-moment revealed significant differences between the 
CLS and CLT student forms. When a more conservative 
examination, the continuity correction, was applied, the same 
9 out of 10 results were significant.
For 8 of the 10 peripheral blood smear reports for 
qualitative white blood cells, the Pearson product-moment 
revealed significant differences between the CLS and CLT 
student forms. When a more conservative examination, the 
continuity correction, was applied, 7 out of 10 results were 
significant.
For 10 of the 10 peripheral blood smear reports for 
qualitative red blood cells examination, the Pearson product- 
moment revealed significant differences between the CLS and 
CLT student forms. When a more conservative examination, the 
continuity correction, was applied, 10 out of 10 results were 
significant.
For 9 of the 10 peripheral blood smear reports for 
identification of clinically significance findings, the 
Pearson product-moment revealed significant differences 
between the CLS and CLT student forms. When a more 
conservative examination, the continuity correction, was
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applied, the same 9 out of 10 results were significant.
When chi square data did not achieve a minimum expected 
value of 5, these data were were analyzed using Fisher Exact 
Tests. Six out of the 10 data sets examined in this fashion 
were deemed clinically significant. The likelihood ratio and 
the Mantel-Haenszel test for linear association were included 
in this study as additional verification of the degree of 
statistical significance shown by the more traditional 
statistical analyses of chi square, Pearson product-moment 
and continuity correction.
The data clearly demonstrated a significant difference 
between the abilities of these cohorts. While true in the 
other categories, the difference described in the category of 
clinical significance is especially important. In the 
clinical laboratory, the issue of false positive and false 
negative reactions is always present. Typically one prefers 
false positive values over false negative ones in that follow 
up or confirmatory tests can be used to clarify the 
situation. But the situation of a false negative results can 
be grave. To fail to recognize cellular elements that are 
essential to the development of a diagnosis can result in 
inappropriate or no therapy and could be life threatening.
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Summary
Given the extent of the statistical examination 
presented, it is fair to state that both the examination of 
the raw data by arithmetic means (mean and standard 
deviation) and the detailed comparison and correlation 
studies performed suggest rejection of the null hypothesis 
that stated there would be no difference between the 
competence of an entry level clinical laboratory technician 
and an entry level clinical laboratory scientist in the 
performance of a peripheral blood smear differential as 
evidenced through a comparison of the results of means, chi 
square tests, and other appropriate statistical tools.
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CHAPTER 5: SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Introduction
There can be no more important task for the 
director of a clinical laboratory than to assess the 
precision and accuracy of the analytical procedures 
under his/her supervision. Maintenance of high 
standards of analysis not only serves as a scientific 
stimulus for the laboratory but is also of direct 
benefit to patients. (Sunderman, 1992, page 1205)
F. William Sunderman, M.D. wrote that statement in his 
retrospective series on the conceptual origins of proficiency 
testing and quality control. Most practitioners in the 
clinical laboratory would agree on the need for accuracy and 
precision. Toward that end, they use multiple level quality 
control specimens, standards produced at the highest level of 
accuracy, moving averages, replicate testing, and other in- 
house protocols to assess, correct, or maintain quality. The 
one element that has been lacking in this process is the 
evaluation of the quality of the personnel performing the 
laboratory procedures. If one were to believe the current 
employment practices, then one might believe there is no 
significant difference between clinical laboratory scientists 
and clinical laboratory technicians in the performance of 
laboratory tests. Throughout their early history,
wiiau cL mwj.c? cuucaucu Wuxrw luxcc
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would provide laboratory results of better quality. The 
assumption that education would have a positive impact on the 
level of accuracy has only been tested once in the Lunz, 
Castleberry, James, and Stahl study between certified medical 
technologists and on-the-job trainees. This study was flawed 
in that the on-the-job trainees were from diverse educational 
backgrounds and the medical technologists had varying years 
of experience.
In contradiction to their own history, pathologists 
created laboratory position for lesser trained personnel and 
claimed that accuracy would not be affected as laboratory 
tests became more sophisticated and complex. During the 20+ 
years of this situation, no study was performed to verify 
that claim. This study was an attempt to assess that claim 
more rigorously that the previous attempt by developing 
cohorts with educational attainment proportional to their 
program of study in clinical hematology.
Proficiency tests have, for several decades, been used 
to monitor and improve performance of clinical laboratories. 
Peer group comparison is the most frequently used basis for 
judgment of performance in the United States. In Germany and 
Finland, the use of means established by referee laboratories 
or groups is preferred. Specifically, in Finland, the 
proficiency test specimen for peripheral blood differentials 
is a glass slide with a stained sample of blood. With the 
exception of the state of Wisconsin, in the United States 
this method has been given limited use on the grounds of
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preparation,cost, and transport issues. As a consequence, 
the preferred method is Kodachrome slides.
In addition, as with all forms of proficiency testing 
used in the United States, there is no consideration of the 
person identifying the cells in the proficiency program.
This allows the "laboratory" to be tested without the actual
persons who comprise the laboratory staff to be tested. As a
consequence, it is possible to assert that the "laboratory" 
is capable of performing cell identification when, in point 
of fact, only one person in that laboratory has been proven 
to do so. The fallacy to this approach is, of course, that 
only one of these persons (not in a group) will be performing 
this test on the next patient while in fact, only the one 
person (or the unofficial group mind) who always performs the 
proficiency tests has been proven to be competent via
proficiency tests to perform this procedure.
This dehumanization of the individuals who perform 
laboratory procedures takes away both the responsibility of 
the individual and the acknowledgement of their essential 
worth. According to Fukuyama (1993), this situation sets up 
a situation in which the fundamental needs of respect and 
acknowledgment are missing.
The certification examinations taken by both associate 
level and baccalaureate level practitioners provide one to 
two opportunities during the examination to identify blood 
cells through color plates. A candidate taking the 
examination is directed to a specific cell on a specific
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plate. The various certification agencies do not currently 
believe that the inability to correctly identify that cell is 
sufficient cause for the agency to deem the candidate as 
unsuitable for certification.
Eighty-seven students from programs throughout the 
country completed 10 peripheral blood microscopic 
evaluations. Students from baccalaureate clinical laboratory 
science program were significantly more accurate in their 
assessments of all phases of the microscopic evaluations. 
Where they were the weakest, although still statistically 
significantly better than their clinical laboratory 
technician counterparts, their consistent error in the 
qualitative white blood cell and red blood cell evaluations 
was in overcalling elements, not in failing to recognize 
them.
For example, in the most egregious case, slide 2641, 
clinical laboratory science students overstated the degree of 
red cell abnormality, although over 80% correctly identified 
the aberrant white blood cells that diagnosed the condition. 
One could posit that they recognized the condition 
represented on the peripheral blood slide and "went looking" 
for the classical red cell representation, which was not 
present in this case. Of more importance are the data that 
showed that more than half of the clinical laboratory 
technician students actually did not recognize the diagnostic 
white blood cells found in chronic lymphocytic leukemia.
There are only two equally damning conclusions for this
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error: (a) the students simply did not recognize the cells or 
(b) the areas of the peripheral blood slide on which they 
chose to perform their evaluation were inappropriate. The 
failure to report platelet evaluations which was the single 
most common reporting error of the clinical laboratory 
technicians either speaks to a somewhat cavalier attitude 
towards the study that cannot be discounted or a more serious 
lack of commitment to thoroughness or detail that might cause 
serious consequences to the patient.
Based on the data and their interpretation, the null 
hypothesis has not been supported by any arithmetic or 
statistical tests.
Conclusions
This study suggests that there are clear and provable 
differences in the abilities of clinical laboratory science 
students and students in clinical laboratory technician 
programs. If Howard Gardner is correct in his thesis on 
robust and naive learning theories, then it is possible to 
postulate that the abilities of clinical laboratory 
technicians to correctly identify peripheral blood cells will 
not improve in any significant way unless directed probing 
reeducation and/or retraining is undertaken (Gardner, 1991). 
While the public may have assumed that more education and/or 
technical training would result in increased accuracy and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
124
precision in the clinical laboratory, the pathologist 
overseers of the evolution of this field did not think that 
it would matter. Clearly, in this study, it does.
Although small in number of participants, this study has 
shown that there are educationally based differences in the 
ability of personnel to perform accurate peripheral blood 
differentials. Sufficient levels of accuracy were not 
obtained by the associate degree personnel and this outcome 
has to be evaluated by organizations as they view the 
structure and work flow of our national hematology 
laboratories.
Individual Laboratory Implications
In this era of cost containment and reorganization in 
the medical care delivery system, it has been economical to 
replace higher paid clinical laboratory scientists with 
clinical laboratory technicians. This replacement has been 
justified by the belief that both are equally capable of 
performing many, if not all, of the testing procedures 
available in the standard clinical laboratory. That belief, 
as mentioned previously, was never put to any test until now. 
These data suggest that this supposition is not the case for 
the performance of peripheral blood differentials. Clinical
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laboratory technicians who perform peripheral blood 
differentials may not be providing the high level of accuracy 
or precision that they should. As a result, patients may not 
be receiving the quality of care that they need.
If the conclusions of this paper are supported by 
additional data, then administrators of clinical laboratories 
should seriously consider their hiring practices and their 
functional scheduling. This has financial impact in that the 
clinical laboratory scientists will be expected to be paid 
more and treated differently. In turn, one might be able to 
predict the potential for a cost savings reflecting a greater 
trust in the accuracy of the results as expressed by fewer 
repeat requests for CBCs.
Professional Implications
From the early part of the 2 0 ^  century, pathologists
have dominated the professional of clinical laboratory 
science, arbitrarily determining the entry levels for a 
profession not their own. While it is true that their 
initial desire for an educated work force was beneficial, 
their continued restructuring and manipulation of these entry 
levels has created disharmony and contention throughout the 
field. That there are over 15 professional organizations all 
claiming to represent the interests of the clinical 
l2bcrstorjf i.s svidsncs to this.
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The pathologists' continued control over one of the two 
national certification examination agencies (Board of 
Registry of the American Society of Clinical Pathologists) 
and the category of associate membership without voice or 
vote in the American Society of Clinical Pathologists speaks 
to an issue that Fukuyama discusses in his book, The End of 
History and the Last Man, in which he claims that that each 
person carries within himself or herself a need for respect 
and acknowledgement from others. For the past century, 
pathologists have placed clinical laboratory practitioners in 
a subservient position. Historical documents have proven 
that clinical laboratory practitioners have continuously 
sought to wrest their profession away from the pathologists 
by first creating an independent professional organization, 
followed by the court cases that removed the requirement to 
work only for a pathologist from the standards of 
certification maintenance, and finally the creation of an 
autonomous credentialing agency run for and by the 
practitioners of laboratory science. One element of the 
pathologist control has been in the creation and delineation 
of the various roles and responsibilities of the 
practitioners. No one ever questioned that right to do so. 
This study proves their assumptions to be less than correct 
and adds more credence to the belief that this profession 
should be independent of pathologist intervention if serving 
the needs of the patient being examined is a goal worthy to 
be attained.




This study was limited in the number of participants. 
Because of its potential impact, it needs to be replicated 
either in multiple small studies or in a national study. One 
problem with either of these options will be the willingness 
of the students in the clinical laboratory technicians 
programs across the country to participate. Another issue 
will be the potential for these students to utilize texts, 
seek out advice or otherwise treat the study as most clinical 
laboratory practitioners do traditional proficiency testing 
specimens - simply keep redoing and redoing the differential 
until they are satisfied with their results or by devising a 
"group" report.
Because the statistically weakest component of the study 
was the qualitative analysis of the red blood cell 
population, the next study might emphasize the red blood 
cells population. This emphasis should not diminish the 
importance of the white blood cell identification since many 
of the most serious diseases (e.g., leukemias, lymphomas, 
infections) are demonstrated in the white blood cell 
population.
One study that might be possible on a large scale would 
be to review several iterations of both levels of the
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certification examination to excerpt the data applicable to 
those questions that required identification of peripheral 
blood cells. While this would assess the ability of 
individuals to correctly identify cells once they have been 
pointed out, it would not assess their ability to chose the 
correct area on the peripheral blood slide, a concept of 
concern given the data on slide #2641.
Another aspect of the current situation impacted by this 
study would be the educational process of both levels of 
personnel. If, as was shown, there was significant 
difference in accuracy with the baccalaureate personnel as 
the more accurate, employers should not allow the associate 
degree employees to perform the test. This would cause 
educators to revamp their curricula to support the new work 
paradigm by eliminating differentials from the associate 
degree curriculum, for example. If, on the other hand, there 
was no separation in accuracy, then baccalaureate programs 
could move away from routine testing in favor of newer or 
more sophisticated testing and management. Employers would 
also take the opportunity to restructure their pay scales 
according to the work performed.
Social Issues
If the level of education is important to the accurate
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possible to ask if levels of education are important in other 
arenas that have experienced the creation of lesser educated 
personnel? Certainly, the pages of the Chronicle of Higher 
Education have been filled in recent years with anecdotal but 
passionate discussions concerning the relationship between 
the purported decrease in quality of education found at 
colleges and universities throughout the country and the 
increased reliance on part-time instructors. A recent news 
items in the lay press concerning the error rate of pharmacy 
technicians in the preparation and dissemination of 
prescription medications could give one pause (Hendren,
2001).
In an interesting coincidence, during an informal 
conversation that touched upon the medical importance of the 
laboratory, a physician commented that most of his colleagues 
would not be surprised at the outcome of this study since 
they routinely experience a significant difference between 
the CBCs reported by the night staff and the CBCs reported by 
the day staff.(personal communication, March 26, 2001) Is 
the health care delivery system providing inaccurate data at 
a level that interferes with appropriate and timely patient 
care? While outside of any data from this study, one might 
wonder if this same difference in quality occurs in other 
fields that have experienced the recent development of 
assistants. For the past decade and more, the business 
mantra of "more with less" has been a powerful force in the 
health care delivery system in the United States. If this
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study is an indication, the patient public might be getting 
"less with less."
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Appendix A
The Values and Standard Deviations for the Ten Peripheral 
Blood Smears as Constructed by the Rajamaki Method
#1025 Chronic Myelogenous Leukemia
The differential to be achieved by the test 
participants is:
Cells average results of Range of results
experienced acceptable by
practitioners Rajimaki method
polymorphonuclear 69 +/-6.0leukocytes +/-3.50lymphocytes 12 +/-2.50monocytes 5 +/-0.23eosinophils 1 +/-0.43basophils 1 +/-4.71bands 5 +/-2.22metamyelocytes 4 +/-3.32myelocytes 5 +/-0.65promyelocytes 1 +/-0.71myeloblasts 2 +/-0.59anisocytosis 2+ +/-0.79poikilocytosis 2+ +/-0.87hypochromia 2+ +/-0.51macrocytosis 1+ +/-0.24polychromasia 1+ +/-0.67spherocytosis 1+ +/-0.46leptocytosis 1+ +/-0.49NRBC 1 +/-0.32burr cells 1+ +/-0.00tear drop cells 1+ +/-0.00ovalocytosis 1+ +/-0.40toxic granulation 2+ adequateplatelets adequate
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Typically diagnosed by the hematology laboratory 
utilizing the differential, this malignancy is 
characterized by the presence of all stages of cellular 
maturation in the myeloid (bone marrow) cell lines. The 
presentations can range from purely granulocytic to a 
mixed granulocyte/monocyte to a mixed 
granulocyte/monocyte/erythroid/megakaryocytic dyscrasia. 
In this presentation, the more classic picture of 
granulocyte immaturity is present. Immature red cells 
(nucleated red blood cells or NRBC's) are seen in small 
numbers although the degree of red cell distortion and 
damage is significant and the platelet estimate is within 
reference limits.
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#2641. Chronic Lymphocyte Leukemia





























































This disease is also first diagnosed by the peripheral 
blood differential as it usually has no overt signs or 
symptoms in its early stages. It is characterized by a 
malignant increase in a single clone of mature looking 
lymphocytes. In early stages, both the red blood cells and
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the white blood cells will show adequate numbers but with a 
significant degree of abnormality in size and shape. The 
platelet populations can have an extremely wide range, 
appearing as decreased, increased, or within reference 
limits.
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#3037 Megaloblastic anemia




























































One of the most common side effects of oncologic 
chemotherapy is the establishment of a folic acid 
deficiency through the use of drugs that interfere with 
folic acid utilization by cells. The principle is to 
deprive the malignant cells of mitotic activity, thus
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causing cell death. As a consequence, all oncologic 
patients taking "folate antagonist" drugs become 
functionally folic acid deficient. The leukocyte count is 
generally low with a normal distribution of cells.
However, the granulocytes display a characteristic set of 
damages, specifically toxic granulation and 
hypersegmentation of the nucleus. Red cells show changes 
in size (macrocytic) and shape (ovalocytes) while the 
platelets remain either within reference range or 
decreased.
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#4599 Status post splenectomy





















The spleen is responsible for the final quality of 
both red cells and platelets. During the red cell's first 
and second passage through the spleen, assorted inclusions 
such as Howell Jolly bodies, Pappenheimer bodies, nuclei, 
and RNA are removed by the splenic macrophages. During 
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lost and the cell shape changes from flat to biconcave. 
Thus, when the spleen is removed, all of these inclusions 
as well as highly distorted shapes can be seen in the 
peripheral blood. The spleen is also responsible for the 
final maturation of the platelet. During its time in the 
spleen, the platelet membrane fully matures and the 
concentration of various coagulation factors such as 
Factors V and VIII are accumulated. At any time, over 30% 
of the total platelet mass is stored in the spleen. Thus 
spleen removal will cause an increase in the total 
circulating platelet count. Just as platelets are stored 
in the spleen, a small number of granulocytes are also 
stored in the spleen so another consequence of splenectomy 
is a slight increase in granulocytes.
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#5797. Leukemoid Reaction









































0 . 0 0  
+/-0.49 
adequate
In patients with several bacterial infections, there 
can occur an unusual granulocytic presentation, not unlike 
that seen in chronic myelogenous leukemia. This 
presentation is identified only by the differential; 
clinical data such as the history, physical and current 
status rpovide important information to discriminate 
be4tween these two diferentials. But there are many
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situations in which the initial diagnosis of chronic 
myelogenous leukemia is made as a result of an initial 
presentation of bacterial infection. The final elements 
needed to verify the diagnosis include additional 
specialized laboratory testing. The RBC cellular elements 
are less striking than those seen in CML. However, the 
white blood cell features are impressive with the presence 
of multiple stages of granulocyte maturation including 
myeloblasts.
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#8924 - Myelodysplasia
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One of the more difficult groups of disorders to 
diagnose from either clinical or laboratory data are the 
myelodysplastic syndromes. Ranging from a mild 
pancytopenia to an overt leukemia, these presentations 
closely resemble each other. One common characteristic is
Appendix A
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the universal decrease in all cell lines which can be 
appreciated through the cell counts by the estimation of 
cells found on the peripheral blood smear. The addition of 
the actual cell counts in this one situation makes the 
separation of the myelodysplastic syndromes much easier. 
However, for the purpose of this study, diagnosis or the 
subcategoriation of a particular condition is not required. 
This study requires that the paticipants correctly identify 
the cells which are common to all of the myelodysplastic 
syndromes. The presence of low numbers of immature 
granulocytes in the absence of an elevated white cell 
count, together with cellular anomalies such as toxic 
granulation and hypersegmented polys, are the most common 
clues.
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#81903- Acute Bacterial Infection
























One of the most important differentials to perform 
requires the identification of the signs of an acute 
bacterial infection. The stress of combating the infection
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forces a shorter transit time during the cells' maturation, 
causing immature cells to be forced into the peripheral 
blood and immaturity seen in the organelles of the cell 
itself. These attributes of immaturity include toxic 
granulation, Dohle bodies, and pseudo Pelger Huet cells.
In addition, because the cell's function is phagocytosis 
and intracellular killing of bacteria, it is common to see 
areas of degranulation within those cells that have emptied 
the contents of their granules during intercellular kill. 
Red cells are typically not affected by this process unless 
the bacteria is producing some type of specific toxin 
against them. Platelets are typically increased due to the 
presence of acute phase reactants as part of the body's 
national defense of itself.
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#80506 HIV infection
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This serious disorder's differential is marked by a 
significant decrease in the presence of lymphocytes which, 
due to the reporting mechanism of percentages, appears as 
an increase in the number of granulocytes. This may also 
occur if the patient is experiencing a bacterial or fungal 
infection which are common consequences of this disease.
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Due to the various medications found in the currently 
accepted "HIV cocktail," there is a significant 
malabsorption in the small intestine which causes a 
combined iron and folate deficiency. This combined 
deficiency is seen in the wide range of red cell sizes and 
shapes. Hypersegmented polys, a hallmark of both vitamin 
B12 and folate deficiencies are also present. Platelet 
production is typically depressed.
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#9219 Compensated hemolytic anemia.
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Diuretics frequently produce the adverse side effect 
of a mild hemolytic state. This is typically compensated 
by increased red cell production. This often results in a 
variation of red cell size and shape with little to no 
change in white cell or platelet numbers or quality.
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#9326 Microangiopathic anemia






























































Patients who have had vascular surgery e.g., valve 
implantation, venografting, stent implantations, or joints) 
or who have damage microvasculature linings due to inoperable 
damage (ie.g., fibrosis, metastatic malignancy, and the like) 
frequently develop a hemolytic anemia due to the destruction
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the red cells against the artificial or abnormal surfaces. 
This condition is frequently accompanied by a stress on the 
bone marrow which is evidenced by the presence of toxic 
granulation of the leukocytes and a decrease in the number of 
platelets as they are used up by the secondary clotting 
process that is occurring in the micro circulation.
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Appendix B
Directions for the Differential Report Form
Thank you for volunteering to perform this survey. 
Please take the time to read over the directions carefully. 
If you have questions, please contact me before you begin. 
My office phone number is (508)999-8786.
You have been given 10 slides on which to perform standard 
differentials. Write your results on these forms. They are 
lengthy in order to provide you with all possible answers. 
If you see something that I forgot to list, please add it.
It is impossible to construct a concise and usable form
that will list all of the varied presentations that can be 
found in a peripheral blood smear. As a consequence, I am 
asking that you include what you see and not be biased by 
any omissions from the file you might notice.
Perform these differentials as if they were part of your 
routine workload. When you are finished, bring the forms to 
your faculty member. When all of the sets are completed,
they will be mailed to me.
Please do not ask for any help or discuss your findings 
until all of your colleagues have completed their 
differentials. Since this survey will determine consistency 
of results, its validity depends upon your complete 
independence.
You will notice that I have included various synonyms for 
certain white blood cells (polys and bands vs. segmented 
and nonsegmented forms as well as atypical vs. reactive
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lymphocytes). Please use the terms with which you are most 
familiar.
Specific Differential Directions
1. The differential should total 100 white blood 
cells plus any nucleated red cells. Cells not seen need not 
be given a "0".
2. If a characteristic of a cell line is seen (ex., 
polychromasia) or a specific cell type (ex., hypersegmented 
poly), report it as you would in your facility.
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Peripheral blood smear number
. (1) polys (11) toxic granulation
(2) bands (12) degranulation
. (3) segmented neut. (12) abn. granulation
. (4) non-seg. forms (13) vacuoles
(5) metamyelocytes (14) Pelger Huet polys
. (6) myelocytes (15) hyperseg. polys
. (7) promyelocytes (16) abn. nuc. appen.
. (8) myeloblasts (17) Auer rods
. (9) eosinophils (18) Dohle bodies
(10) basophils (19) bact. inclusions
. (21) lymphocyte (31) monocytes
. (22) reactive lymph (32) degran. mono's
. (23) atypical lymph (33) vacuoles in mono's
. (24) abnormal lymph (34) young monocytes
. (25) prolymphocyte (35) monoblasts
. (26) lymphoblast (36) macrophage/
. (27) vacuolated lymphs histiocyte
. (28) plasma cell (41) white cell blast,
. (29) Mott cell undifferentiated
Appendix B
















(71) other (please explain)
Please tell me a little about yourself:
age   Program: associate
baccalaureate
gender ________  (please circle)
ethnicity ________
Have you had any experience in a clinical laboratory prior 
to this degree program? YES NO
If yes, how long _____  and in what department _____________
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Appendix C
DEFINITIONS OF BLOOD CELLS THAT MAY BE VISUALIZED 
ON A PERIPHERAL BLOOD SMEAR
Myeloblast: They are variable in size but usually large 
(15-20^m). The nucleus is delicate, with prominent nucleoli. 
The meager cytoplasm contains rough endoplasmic reticulum, a 
developing Golgi apparatus, and, as it matures through its 
life cycle, an increasing number of azurophilic granules. The 
presence of this cell in a peripheral blood smear is strongly 
suggestive of leukemia or myelodysplasia.
Promyelocyte (Progranulocyte): After several days in the 
blast stage, the cell progresses to the promyelocyte stage. 
Its size is variable, often exceeding 20|im, which is 
occasionally larger than the size of its precursor cell. The 
nuclear chromatin pattern may be as delicate as that of a 
myeloblast or may show slight clumping. Nucleoli begin to 
fade. Granules are present throughout the larger cytoplasm 
and on top of the nucleus. The presence of this cell in a 
peripheral blood smear is strongly suggestive of leukemia, 
myelodysplasia, or life threatening infection or trauma.
Neutrophilic Myelocyte: This cell is usually smaller 
than the promyelocyte and constitutes less than 10% of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
214
total marrow cell population. The nucleus may be round to 
oval with a flattened side near the well-developed Golgi 
apparatus. The nuclear chromatin shows clumping, and nucleoli 
are usually no longer visible. The secondary granules alter 
the staining reaction within the cytoplasm. They cause a 
"dawn of neutrophilia," or faint blush of pink first seen 
near the Golgi apparatus within the cytoplasm. They are seen 
in the peripheral blood in leukemia, myelodysplasia, 
infections, trauma, and drug reactions and occasionally in 
association with fevers and severe exercise.
Neutrophilic Metamyelocyte: The traditional 
discriminator between myelocyte and metamyelocyte is the 
shape of the nucleus; that of the metamyelocyte becomes 
indented. In reality, the shape of the myelocyte nucleus 
varies from round to deeply indented. By this stage, the 
cytoplasm has a complete collection of primary and secondary 
granules
Neutrophilic Band (Nonsegmented Form): The definition 
and name of this intermediate form have been debated 
extensively. In one classification system, its discrimination 
is based on the presence or absence of nuclear segments made 
up of dense heterochromatin. The terms segmented and
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"nonsegmented" are used in this definition of these cells. 
Another classification requires that the outer shape of the 
nucleus have uniform or parallel width (C or S shape) as its 
basis and identifies a cell whose nucleus is so described as 
a "band" and cells with all other nuclear forms as 
"polymorphonuclear neutrophils." Finally, a third 
classification system defines a band as a cell whose nuclear 
indentation is less than half the width of the nucleus and a 
polymorphonuclear neutrophil as a cell whose nuclear 
indentation is more than half the width of the nucleus. This 
third system reflects an appreciation of the role of change 
and maturity within the cell, for chromatin maturity is also 
used as a criterion.
Polymorphonuclear Neutrophil (Segmented Neutrophil, PMN, 
Gran): The cell's nucleus continues its indentation until 
thin strands of membrane and heterochromatin form into 
segments and create a lobated nucleus. This nucleus is easily 
deformable because of the active motility of the cell. The 
name polymorphonuclear means "many-shaped nucleus" and 
accurately describes the nuclear shapes. Most nuclei have 
visible segments, although some appear grossly twisted or 
folded. According to the traditional Arneth count, nuclei 
should have between two and four lobes. A lesser amount
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indicates either immaturity or genetic anomaly; a greater 
amount suggests difficulty in maturation.
Eosinophil: The adult eosinophil typically contains a 
nucleus that is in band form or bilobed. Nuclei with higher 
lobe counts are seen rarely. The cell is slightly larger than 
the average neutrophil and may have an irregular border as a 
result of motility. The eosinophil is distinguished from the 
neutrophil by the presence of numerous, large, round granules 
containing a crystalloid compound made up of major basic 
protein (MBP). Eosinophils are increased in parasitic 
infections, allergic responses, drug reactions, and lead 
poisoning.
Basophils: Similar in size and shape to eosinophils, 
basophils are characterized by the presence of large, heavily 
staining granules. These granules differ from those of the 
eosinophil in that they are irregularly shaped, unevenly 
distributed throughout the cell, and turn a deep purple to 
black with Romanowsky stains.
Monocyte to Macrophage: Macrophages are large, actively 
phagocytic cells with a size range of between 15-85nm in 
diameter. Their shape is pleomorphic and, because of their
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motility, are frequently seen with pseudopods. The function 
of the monocyte/macrophage is phagocytosis, and the material 
ingested is seen in variably sized phagosomes.
Lymphocytes: The morphology of the lymphocyte, when seen 
with the aid of Wright's stain, varies mostly by size. The 
size discrepancy may be due to the activity of the cell or 
the location in the smear in which it is found. Cells in 
thick areas of the smear tend to be rounded up and to appear 
smaller and thicker than they actually are. The most common 
form is the small lymphocyte, which is approximately 9̂ im in 
diameter with skimpy cytoplasm and a few azurophilic 
granules. The nucleus is round to oval, and its chromatin 
pattern is a block type. This cell has been described as 
nondividing or resting.
The medium-sized lymphocyte is approximately 11— 14|im in 
diameter. Its cytoplasm usually contains azurophilic granules 
that are more clearly discerned, probably as a result of the 
larger amount of cytoplasm in which they are found. Although 
these cells are larger than the small lymphocytes, their 
nucleus-to-cytoplasm ratios are essentially the same. Like 
the small lymphocytes, these cells are considered 
nondividing.
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The rarest of the peripheral blood lymphocytes is the 
large lymphocyte. It is approximately 15nm or more in 
diameter, and the more generous cytoplasm usually turns a 
deeper shade of blue when stained. The usual block-type DNA 
is spread a little more loosely.
Reactive Lymphocyte: These cells are highly pleomorphic. 
In comparison with the nucleus of a common lymphocyte, the 
nucleus of the reactive lymphocyte is less clumped; faintly 
stained multiple nucleoli are more likely to be seen. 
Chromatin patterns are generally less striking in the 
reactive lymphocyte; some patterns appear quite similar to 
those of a blast. The shape of the common lymphocyte nucleus 
is round to oval; that of the reactive cell nucleus ranges 
from elliptic to cleft to folded. The cytoplasm has greater 
variability in morphology than does the nucleus. The 
cytoplasm may range from large, deeply basophilic, and 
abundant to unevenly stained and granular. A Golgi apparatus 
is commonly seen. A variant of reactive lymphocyte is the 
plasmacytoid lymphocyte whose appearance is somewhere in 
between those of the lymphocyte and plasma cell.
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Pelger-Huet anomaly: Clinically insignificant because
there is no loss of cellular function, and inherited through 
autosomal dominance, the keys to identification are (1) 
nuclei that are round, oval, or bilobed with a characteristic 
pinched or pince-nez appearance; (2) clumping of the 
chromatin is overly mature for the overall shape of the 
nucleus; and (3) most cells look alike. The rare homozygote 
has rounded nuclei. Pseudo Pelger-Huet cells are acquired 
phenomena that may be clinically significant. These cells 
have nuclei that are less dense than those of normal cells or 
true Pelger-Huet cells, and they may have hypogranular 
cytoplasm. Pseudo Pelger-Huet cells are found in high stress 
situations (such as burns, drug reactions, and infections), 
myelodysplastic syndromes, chronic granulocytic leukemia, and 
acute leukemia.
Hypersegmentation: Having more than 5 lobes in the 
nucleus is classified as hypersegmentation and is seen in the 
megaloblastic anemias (vitamin B12 or folate deficiency or 
point mutations affecting DNA replication) and from acquired 
hypersegmentation (also known as twinning deformity). 
Hereditary hypersegmentation of granulocyte nuclei, inherited 
through autosomal dominance, is clinically insignificant.
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Twinning: A term that describes a nucleus exhibiting 
axial symmetry or presenting a sense of mirror imagery in the 
construction of the nucleus. Twinning is an acquired anomaly 
and is clinically significant in stress situations, 
malignancies, and treatment with some oncologic regimens
Drumsticks: These are small extrusions of nuclear 
material may be found in persons with trisomy of group E 
chromosomes, with extra 'X' chromosomes, or with other 
aneuploidy states.
Alder-Reilly anomaly: This presentation may be 
transmitted as a possible recessive disorder in which 
decreased mucopolysaccharide degradation results in 
deposition of mucopolysaccharides (lipids) in the cytoplasm 
of most, if not all, cells. When stained, these deposits 
called Alder Reilly bodies, appear as metachromatic (deep 
purple to lilac) granules and may be difficult to distinguish 
from toxic granulation, they condition is life threatening 
with death occurring form infections.
Chediak-Higashi syndrome: this is a rare autosomal 
recessive state in which abnormally large peroxidase-positive 
lysosomes in all cells of the body, especially those of the
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peripheral blood. This condition is lethal by the age of 10 
years.
May-Hegglin anomaly: This is a rare autosomal dominant 
condition in which patients are at risk for infections and 
bleeding. This anomaly is characterized by the presence of 
large, Dohle body - like formations in all cells, 
thrombocytopenia, and giant platelets with abnormal platelet 
function and lifespan. Dohle bodies develop in the cytoplasm 
of granulocytes of patients with infections or in stress 
states, are round to oval, are approximately l-5nm in 
diameter, and are composed of parallel rows of ribosomal RNA. 
Patients with May Hegglin do not live past their teenage 
years.
Toxic Granulation: This acquired demonstration of
abnormally large or dominant primary granules is called toxic 
granulation and is a stress response to infection, 
inflammation or treatment with stimulants and must be 
differentiated from Chediak Higashi and May Hegglin 
anomalies.
Phagocytic vacuoles: These unstained areas in the 
cytoplasm may be found in neutrophils as a result of various
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situations. Autophagocytosis (phagocytosis of self) is 
usually seen with prolonged exposure to drugs such as 
antimicrobial agents and to toxins such as alcohol and 
radiation. Vacuoles caused by the ingestion and degradation 
of bacteria or fungi are larger than those seen in 
autophagocytosis, are not as evenly distributed, and are 
considered clinically significant, especially when associated 
with toxic granulation, degranulation, and/or Dohle bodies.
Auer Rods: A fused collection of primary granules in the 
myeloid cells that is pathognomic acute leukemia.
Platelets: As platelets enter the peripheral blood 
circulation, their average diameter is 2.5 microns. 
Unstimulated platelets are lentiform discs with smooth 
margins. The platelet structure can be divided into the 
peripheral, sol-gel, organelle and membrane zones. Increases 
and decreases in platelet numbers can be associated with 
bleeding or clotting. Qualitative alterations in the 
platelet themselves also mirror changes in function.
Immature and abnormal forms include large, gray, nongranular 
platelets. Megakaryocytic fragments, megakaryoblasts and 
micro megakaryoblasts are seen in leukemias and 
myelodysplasia.
Appendix C
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
223
Plasma Cell: The fully committed B lymphocyte is found 
in rare numbers in the normal peripheral blood. Increases 
occur in myeloma and responses to vaccinations.
Mott Cell: A variant of the plasma cell can be seen in 
myeloma or severe immunology responses.
Pronormoblast: The earliest recognizable red cell is 20 
- 25nm in diameter with a rounded to oval nucleus that 
occupies 80% of cell. The nucleus has fine chromatin and one 
or more well defined nucleoli while the cytoplasm is 
intensely blue
Basophilic normoblast: The next cell is 6 - 18^m in 
diameter with a - nucleus that occupies 75% of cell. There is 
some nuclear heterochromatin; a Golgi apparatus is visible.
In the cytoplasm, there is a possibility of some hemoglobin 
production visible
Polychrcmatophilic normoblast: This cell is 12 - 15pim.
The nucleus occupies less than 50% of cell and its 
heterochromatin is well defined. A nucleolus is no longer 
visible. There is significant hemoglobin production 
completed.
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Oxthochromic normoblast: Also known as the nucleated red 
blood cell is 10 - 15jim, this is the smallest cell in the red 
cell series. Its nucleus is pyknotic and the cytoplasm has 
approximately 80% of hemoglobin completed.
Anisocytosis: A change in the size of the red cell, this 
is important in the diagnosis of all of the anemias.
Poikilocytosis: This terms means change in shape of the 
red cells. There are over 2 dozen different shape 
possibilities from sickle (diagnostic of sickling hemoglobins 
to spherocytes (diagnostic of hemolytic anemia.)
Howell Jolly bodies: Remnants of the red cell nucleus, 
they are found in the blood stream after splenectomy, during 
severe stress and malaria.
Cabot Rings: Rarely seen, these pieces of RNA structure 
are found in megaloblastic anemias.
Pappenheimar Bodies: These are pieces of unincorporated 
iron in the cytoplasm of the cell. No red cell is supposed to 
have unincorporated iron so any Pappenheimer bodies are 
signals of disturbed hemoglobin synthesis.
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Malaria: This disease is the number one parasitic 
disease in the world. There are four different species, each 
with their own life cycle and treatment. Diagnosis is first 
made in the hematology laboratory during the differential and 
then speciated by microbiologists.
All definitions taken from Rodak, B (ed.) (1997)
Diagnostic Hematology. Philadelphia, PA: W.B. Saunders.
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INTERNET
Activities Clinical Laboratory Testing Consultant for international 1996 - present
bulletin boards for hematology oncology patients 
(Hematologic Malignancies Discussion 
<HEM-ONC@LISTSERV.ACOR.ORG>, Chronic Lymphocytic 
Leukemia Discussion<CLL@LISTSERV.ACOR. ORG>
Myeloproliferative Disease Discussion 
<MPDNET@LISTSERV.ACOR.ORG>, Coagulopathies 
Discussion<COAG@LISTSERV.ACOR.ORG> , andMultiple Myeloma 
Discussion<Myeloma@LlSTSERV.ACOR.ORG>.
Special
Appointments Host, European Union/Shuman Foundation/ UMass Dartmouth 2000
Ceremony to award the Medallions of Two Worlds for distinguished 
Service in the fields of Cultural and Humanitarian Activities 
(Recipients were The United Nations High Commission on Refugee,
The Children's Hospital of Brescia, Italy, Dr. Allan Robinson of 
Harvard University, and Hon. Enrico Vinci of the European Union
Leader and Developer, Dwight D. Eisenhower People to People 1997




Clinical Laboratory Educators' Conference, Salt Lake City, Utah 2000
When A Patient Asks...
American Society for Clinical Laboratory Science Annual Meeting,
San Francisco, CA.
Career Options of the Future: Counseling In and Out of the Hospital 
Georgia State Society for Clinical Laboratory Science Annual Meeting 
Review of Red Cell Moprhology for the Georgia State Society for 
Clinical Laboratory Science Annual Meeting
Tech Refresher: Hematology in the 1990's 1999
Region IX Northwest Symposium, Portland, OR 
Laboratory Testing Counselor
Region IX Northwest Symposium, Portland, OR 
The Clinical Laboratory in the People's Republic of China 
Region IX Northwest Symposium, Portland, OR 
Laboratory Testing Counselor
ASCLS Advanced Hematology/Hemostasis Seminar 
Providence, RI
The Role of the Laboratory in the Diagnosis and Treatment of 
Waldenstrom's Macroglobulinemia
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the second annual meeting of the International Waldenstrom's 
Support Group, San Francisco, CA.
Getting Students Published
ASCLS Clinical Laboratory Educators' Conference 
The Laboratory and Human Relations, Part II 
ASCLS Annual Meeting,
Bioethics: What is it and why to do we need it 
MSCLS/CLMA/AMT Annual Seminar
Update on the Treatment of Acute Progranulocytic Leukemia 1997
New York Society for Clinical Laboratory Science Seminar 
Update on the Treatment of Acute Progranulocytic Leukemia
Vermont Society for Clinical Laboratory Science Annual Seminar 
Update on Treating Acute Myelogenous -3 Leukemia 
Bay Chapter/BRISMeT/RIBBs Seminar 
ASCLS Editors' Forum: Writing Abstracts for Presentations and Publications 
ASCLS Clinical Laboratory Educators Conference, Washington, DC 
National Certification Agency for Medical Laboratory Personnel Update 
ASCLS Clinical Laboratory Educators Conference
Breast Cancer: Controversies and Causes
ASCLS Region I Annual Seminar 1996
Update on the Treatment of Acute Progranulocytic Leukemia 
ASCLS Region I Annual Seminar 
Innovative Teaching Strategies in Hematology and Hemostasis 
ASCLS Annual Meeting 
What Students Need to Know about Computers 
ASCLS Annual Meeting
Breast Cancer and Hematology Changes with Morphology Due to 1995 
Disease and Treatment 
ASCLS Region I Annual Seminar 
Breast Cancer and Hematology Changes with Morphology Due to Disease 
and Treatment
University of Wisconsin - Madison Continuing Medical Education 
Teleconference Series
Hematologic Effects of Breast Cancer Therapy 1994
(P.A.C.E. approved 1 CEU's) ASMT Annual Meeting 
Review of the Hematologic Effects of Oncologic Agents
(P.A.C.E. approved 6 CEU's) Joint Meeting of the Association for Oregon Medical 
Technology and the Oregon State Society of American Medical Technologists 
What Tests to Order Next? - A review of Red Cells (P.A.C.E. approved 3 CEU's)
Joint Meeting of the Association for Oregon Medical Technology and 
the Oregon State Society of American Medical Technologists
How Can Changes in White Blood Cells be Both Good and Bad? - 1993
A review of Conditions that affect White Blood Cells
(P.A.C.E. approved 3 CEU;s)
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Joint Meeting of the Association for Oregon Medical Technology and 
the Oregon State Society of American Medical Technologists 
The Impact of Health Care Delivery System Reform on clinical laboratory science 
20th Anniversary Celebration of the University of Connecticut School of 
Allied Health Professions 
Panelist: Surviving Hard Times: Saving MT Programs
ASMT Region I Annual Seminar, Cromwell, Connecticut
Classification of Lymphocytes and Monocytes 1992
Rhode Island Blood Center, Providence, RI
Careers in Clinical Laboratory Science: Graduate School Options 
MAMT Annual Meeting
Update on the Myelodysplasias (PA.C.E. approved 3 CEU's) 1991
Southeastern New England Society for Medical Technology
Hematologic Effects of Oncologic Agents (P.A.C.E. approved 3 CEU's) 1990 
Empire State Association for Medical Technology Annual Meeting
Case Studies in Hematology (P.A.C.E. approved 1 CEU's) 1989
MAMT Annual Meeting
The Role of Macrophages
Rhode Island Blood Bank Society
Review of the Thalassemias 
Rhode Island Blood Center
How to Computerize a Medical Technology Curriculum 1988
1 day PA.C.E. approved workshop - 6 CEU's 
ASMT Annual Meeting
Case Studies in Hematology (PA.C.E. approved 1 CEU's)
MAMT Annual Meeting
How to Teach Hematology/Hemostasis (P.A.C.E. approved 3 CEU’s) 1987 
ASMT Annual Meeting
Computer Assisted Instruction in Hematology Using a Macintosh™
(PA.C.E. approved 3 CEU’s)
ASMT Annual Meeting
Computer Assisted Instruction Higher Education Computing Conference 
Massachusetts Board of Regents 
Bridgewater State College
Effects of Oncological Drugs on the Patient 1986
(P.A.C.E approved 3 CEU’s)
ASMT Annual Meeting
Hematologic Effects of Oncological Drugs 
(PA.C.E approved 3 CEU’s) ■
Maine/ASMT, Maine/New I lampshire AMT/Maine CLMA Annual Meeting
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Art of Phlebotomy
(P.A.C.E. approved 3 CEU’s)
MAMT Annual Meeting 
Test Construction (P.A.C.E. approved 3 CEU's) 
MAMT Annual Meeting
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Evolution of a Four Year Curriculum(P.A.C.E. approved 1 CEU's) 
ASMT Annual Meeting 
Stem Cell Dynamics in the Erythrocyte (P.A.C.E. approved 3 CEU's) 
ASMT Region I Seminar
Phlebotomy Workshop (P.A.C.E. approved 3 CEU's)
ASMT Region I Seminar 
Moderator, Fisher Lectureship Series 
ASMT Annual Meeting 
Certification Examination Formats (P.A.C.E. approved 1 CEU's) 
MAMT Semi-Annual Meeting
Enzyme Deficiency Hemolytic Anemias
(P.A.C.E. approved 1 CEU's) ASMT Region I Annual Seminar 
The Art of Phlebotomy
(P.A.C.E. approved 3 CEU's) MAMT Semi-Annual Meeting 
Phlebotomy: Specimen Collection and Handling and Collection 
(P.A.C.E. approved 3 CEU’s) MAMT Annual Meeting 
Entrance into Graduate Programs 
MAMT Annual Meeting
Hematology/Hemostasis Problem Solving Session -Moderator 
ASMT Region I Seminar 
Help for the First Time Author/Researcher 
MAMT Annual Meeting 
The Senior Year
MAMT Annual Meeting
Career Awareness Panel 
MAMT Annual Meeting 
Scholarship Opportunities in the 80's 
MAMT Annual Meeting 
Phlebotomy Workshop for Students 
MAMT Annual Meeting
The Art of Phlebotomy Workshop
(P.A.C.E. approved 3 CEU's) MAMT Semi-Annual Meeting 
Opportunities for the Graduate 
MAMT Semi-Annual Meeting
ASMT Professional Expectations and the Clinical Year 
MAMT Annual Meeting 
Coping with the Senior Year 
MAMT Semi-Annual Meeting 
Differentials - Decision Making
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Hematology Question Session - Panel 1979
MAMT Annual Meeting 
The Necessity of Anatomy and Physiology in the College Curriculum 
MAMT Annual Meeting
Correlations of Bone Marrow and Peripheral Blood Smears
(P.A.C.E. approved 6 CEU’s)Ohio Society for Medical Technology Annual Meeting 
Introduction to Bone Marrows Workshop
(P.A.C.E. approved 3 CEU's) MAMT Region I Seminar 
Correlations on Peripheral Smear Morphology and Case Histories 
(P.A.C.E. approved 3 CEU's) ASMT Region I Seminar
The Case Approach to Learning Hematology 1978
(P.A.C.E. approved 3 CEU's) MAMT Annual Meeting 
A Hematology Review
Scientific Products Seminar, Pittsburgh, PA
Affiliations and You - Panel 1977
New Jersey Society for Medical Technology Annual Meeting 
Introduction to Bone Marrow Morphology Workshop 
P.A.C.E. approved 3 CEU's)
MAMT Annual Meeting 
The Problems with Certification Systems 
MAMT Semi-Annual Meeting 
The Internship Problem: Update 1977 
(P.A.C.E. approved 3 CEU’s) MAMT Annual Meeting 
Advanced Red Cell Morphology
(P.A.C.E. approved 3 CEU's) ASMT Region I Seminar 
Licensure and Certification - an Updated Perspective 
(P.A.C.E. approved 3 CEU's) ASMT Region I Seminar 
Hematology Problem Solving Session - Moderator 
ASMT Region I Seminar
What’s the Diff - More Case Presentations 1976
(P.A.C.E. approved 3 CEU’s)MAMT Annual Meeting 
Licensure, Certification, Registration and Continued Competence:
WHO, WHAT and WHY 
MAMT Annual Meeting 
The Internship Problem 
MAMT Annual Meeting 
How to Survive a Self Study 
ASMT Region I Seminar 
Hematology Problem Solving Session 
ASMT Region I Seminar
What's the Diff - Case Presentations 1975
(P.A.C.E. approved 3 CEU’s)MAMT Annual Meeting 
Basic Red Cell Morphology Workshop
(P.A.C.E. approved 3 CEU's) ASMT Annual Meeting
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Differentiation of Lymphs and Monos in the Peripheral Blood 
(P.A.C.E. approved 3 CEU’s)
MAMT Continuing Education Series 
Hereditary Anemias
Southeastern Massachusetts University Student Association for Medical 
Technology "Human Body Institute"
Comprehensive Review of Hematology - 2 day workshop
(P.A.C.E. approved 12 CEU’s) Maine Society for Medical Technology Annual Mtg.
Lymphocyte Morphology #2 1974
Massachusetts Department of Public Health Continuing Education 
Series
Problem Solving in Hematology
SMSMT Continuing Education Series 
Differentiation of Lymphs and Monos in the Peripheral Blood 
(P.A.C.E. approved 3 CEU's)
MAMT Annual Meeting 
Lymphocyte Morphology #1
Massachusetts Department of Public Health Continuing Education Series 
Leukocyte Physiology Workshop 
ASMT Annual Meeting 
Basic Erythrocyte Morphology Workshop 
ASMT Annual Meeting
Red Cell Inclusions 1973
SMSMT Continuing Education Series 
Basic Erythrocyte Morphology 
ASMT Annual Meeting 
Leukocyte Physiology Workshop 
ASMT Annual Meeting 
Lymphocyte Physiology
Massachusetts Department of Public Health Continuing Education Series
Advanced Hematology 2 day Workshop 1972
MAMT Annual Meeting 
Case Studies in Hematology 
MAMT Annual Meeting 
Problem Solving in Hematology 
ASMT Region I Seminar




Robin H. Mendelson Memorial Award for the development of the 
consumer information web page 
Sherwood Kendel Medical Award: Hematology/Hemostasis Section 
University of Massachusetts Dartmouth "Yvonne Sandstroem Memorial 
Award for Outstanding University Service
ASCLS Omicron Sigma Award 1999 
ASCLS Board of Directors' Award
Biographee: Marquis' Who's Who in America 
Biographee: Marquis' Who's Who in Medicine and Health 
ASCLS Omicron Sigma Award
Biographee: Marquis' Who's Who in American Education 
ASCLS Omicron Sigma Award
Biographee: Marquis' Who's Who in the East 
ASCLS Omicron Sigma Award
Biographee: Marquis' Who's Who in Health Service Professionals 
Biographee: Marquis' Who's Who in American Women 
ASCLS Omicron Sigma Award
ASMT Omicron Sigma
ASMT Board of Directors Award - recognition of a successful 
implementation of the society's name change
ASMT Omicron Sigma award
ASMT Board of Directors Award for outstanding service to the 
professional in the construction of the profession's response to 
federal regulatory initiatives in CLLA'88
EduCom/Joe Wyatt Challenge Award for Educational Uses 
of Computers
Biographee: Who's Who in Health Service Professionals 
ASMT Omicron Sigma award
Robin H. Mendelson Memorial Award for service to the 
AMT Education and Research Fund, Inc.
ASMT Omicron Sigma award
MAMT nominee for ASMT Member of the Year 
ASMT Omicron Sigma award
ASMT/Sherwood Medical Award: Hematology/Hemostasis Section 
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Elected Member of Alpha Mu Tau, National Honor Society 
of Clinical Laboratory Science
Biographee: Outstanding Biographies in America 
ASMT Omicron Sigma
ASMT Presidential Certificate of Appreciation
Omicron Sigma Award
ASMT Presidential Certificate of Appreciation
ASMT Presidential Certificate of Appreciation
ASMT Presidential Certificate of Appreciation
ASMT Presidential Certificate of Appreciation
Omicron Sigma Award
ASMT Presidential Certificate of Appreciation
MAMT Member of the Year Award
MAMT nominee for ASMT Member of the Year Award
Omicron Sigma Award
ASMT Presidential Certificate of Appreciation
Omicron Sigma Award




Member, Lambda Tau Honor Society
Community Activities
The Role of the Laboratory Values in Chemotherapy Decisions 
http://healthtalk.com/laboratory
Understanding Your Laboratory Values 
http://healthtalk.com/ASCLS
Waldenstrom Syndrome and the Clinical Laboratory
New York City Waldenstrom Macroglobulinemia Support Group 
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The Role of the Laboratory in the Diagnosis and Treatment of Hepatitis C 
http://healthtalk.com/hepc.htm 
The Role of the laboratory in the diagnosis and Treatment of Breast Cancer 
http://healthtalk.com/bcen/
Waldenstrom Syndrome and the Clinical Laboratory 1999
National Waldenstrom Macroglobulinemia Support Group 
Seminar, San Francisco, CA
The Role of the Laboratory in the Diagnosis and Treatment of Chronic 1998
Lymphocyte Leukemia
http:/ /  www.healthtalk.com/dl.html
Waldenstrom Syndrome and the Clinical Laboratory 1997
National Waldenstrom Macroglobulinemia Support Group 
Seminar, Washington, DC
Cancer: What do we know about it and what can we do about it?
Boston Museum of Science High School Science Series
Sex Education in the 90's - lectures for 7th and 8th grade students 1992
St. James/St. John the Baptist Parochial Grammar School
Sex Education in the 90's - What your students need to know - lecture for teachers 
St. James/St. John the Baptist Parochial Grammar School
two hour AIDS Lectures for each of the 7th and 8th grades 1991
St. James/St. John the Baptist Parochial Grammar School 
St. Francis Xavier Grammar School 
St. Anthony of Padua Parrish Youth Group
Special Lectures on AIDS education for 2 Biology Classes and 2 Psychology Classes 
1988 at Dartmouth High School
AIDS Information Lecture 1987
Biology Dept. Lecture Series 
Roger Williams College, Barrington, RI
In-Service Series on AIDS Education
(different presentations for teachers, parents, junior high and high
school students) for
West Bridgewater School System
East Bridgewater School System
Whitman-Hanson School System
Series on AIDS Education
2 hour cable TV presentation by the Old Colony Cable Co.
potential viewers: city of Taunton and the surrounding towns of East and
West Bridgewater, Raynham, and Wrentham
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Southeastern Massachusetts Health Planning 
and Development. Inc. (SMHPD)
member
President - Board of Directors 
Chair, Management Committee 
Vice-President - Board of Directors 
Chair, NM R/M RI Guidelines Task Force 
Member, Search & Screen Committees for Acute Care Analyst and 
Executive Director 
Secretary - Board of Directors 
Reelected member, Board of Directors 
Chair, Acute Care Committee 
Chair, Long Term Care Committee 
Vice-Chair, Acute Care Committee 
Chair, Plan Development Committee 
Member, Management Committee 
Member, Plan Development Committee 
Member, Board of Directors 
Chair, Acute Care Task Force
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